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Zusammenfassung 
 
Infektiöse Durchfallerkrankungen, wie die durch enterohämorrhagische (EHEC) 
und enteropathogene (EPEC) E. coli verursachten, stellen besonders in Entwick-
lungsländern ein großes medizinisches Problem dar. Symptomlose Langzeitträ-
ger werden als gefährliches Reservoir angesehen, weil sie die Infektion unwis-
sentlich verbreiten. Mit C. rodentium, einem Modelkeim für EHEC/EPEC Infekti-
onen in der Maus, konnten wir in keimfreien Mäusen eine Langzeitinfektion etab-
lieren, um den Einfluss kommensaler Bakterien für die Abwehr von enteropatho-
genen Keimen zu erforschen.  
Es konnte gezeigt werden, dass die normale, intestinale Mikrobiota die Expres-
sion inflammatorischer Faktoren wie IL-17A, CXCL2 und ICAM-1 beeinflusst, die 
an der Migration von Neutrophilen in das Colon beteiligt sind. Zusätzlich konnten 
wir zeigen, dass kommensale Keime die phagozytische Aktivität von Neutrophi-
len und die Konzentration an IgG im Colon erhöhen und somit eine effiziente 
Aufnahme und Abtötung von C. rodentium ermöglichen. Wir konnten weiterhin 
zeigen, dass diese Immunreaktionen in Abwesenheit von Darmbakterien stark 
beeinträchtigt sind, sodass C. rodentium lebenslang in keimfreien Mäusen per-
sistiert und sich vom pathogenen in ein kommensales Bakterium verwandelt.  
 Von enormer Bedeutung ist der Befund, dass die antibakterielle Abwehr durch 
den Transfer von Darmbakterien wiederhergestellt werden kann und es zu einer 
Eliminierung der enteropathogenen Keime kommt.  
Obwohl Infektionen mit C. rodentium im Fokus vieler früherer Forschungsarbei-
ten standen, war bisher noch unverstanden, wie Darmbakterien eine Eliminierung 
der enteropathogenen Bakterien induzieren. Die aus dieser Arbeit gewonnen Er-
kenntnisse können für die präventive und therapeutische Behandlung asympto-
matischer EPEC- Langzeitträger von Bedeutung sein.  
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Abstract 
 
Infections with enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Esch-
erichia coli (E. coli) are a major cause of diarrhoea in the developing world. 
Asymptomatic EPEC-carriers are thought to be an important reservoir for these 
pathogens since they excrete pathogens unknowingly and thereby infect other 
people and spread disease. With C. rodentium we were able to mimic long-term-
carrier situations in mice without gut microbiota. This enabled us to investigate 
how commensal bacteria initiate clearance of enteropathogens.  
During this work, we could show that a healthy gut microbiota influences the ex-
pression of inflammatory factors like IL-17A and consequently CXCL2 and ICAM-
1, thus mediating migration of neutrophils into the colon. Furthermore, we found 
that commensal bacteria enhance the phagocytic activity of neutrophils and in 
parallel elevate colonic IgG levels, subsequently leading to an efficient uptake 
and killing of C. rodentium. However, our findings demonstrate that in absence of 
gut microbiota these immune responses are impaired. As a consequence, this 
leads to a lifelong persistence of C. rodentium, which adapt a commensal-like 
phenotype at late time points of infection. Importantly, we here show that impaired 
immune responses can be restored by the transfer of gut microbiota, thus ena-
bling clearance of the enteropathogen.  
Although many prior investigations have focused on infection with C. rodentium, 
it was not understood how gut microbiota induces clearance of the enteropatho-
gen. The findings from this work might provide information for microbiota medi-
ated preventive and therapeutic treatments of asymptomatic EPEC-carriers. 
 
1 
 
1. Introduction 
 
1.1. EHEC, EPEC and C. rodentium 
 
Infections with enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Esch-
erichia coli (E. coli) are a major cause of diarrhea in the developing world, partic-
ularly in young infants [Nataro and Kaper, 1998]. Infection results in attachment 
and colonisation of the intestinal tract, leading to characteristic attaching-and-ef-
facing (A/E) lesions on the intestinal epithelium, causing transient enteritis or co-
litis in humans [Nataro and Kaper, 1998]. Spread of disease occurs via contami-
nated food or water or via fecal-oral transmission [WHO, 2013]. Some EPEC-
infected adults can become asymptomatic carriers and excreters of enteropath-
ogenic bacteria thus increasing incidence rate [Stevenson 1950, Stevenson 
1952, Thomson et al., 1956].  
Citrobacter rodetium (C. rodentium) is a model organism to study EPEC and 
EHEC infections in mice. All three are gram-negative, rod-shaped enterobacteria 
such as commensal E. coli. Unlike non-pathogenic E. coli, the genome of these 
enteric pathogens harbours a locus of enterocyte effacement (LEE), which car-
ries virulence genes and the global regulator Ler, necessary for A/E lesion for-
mation [Elliott et al., 1998; McDaniel et al., 1995]. This pathogenicity island en-
codes a type III secretion system (T3SS) [Jarvis et al., 1995], the cell adhesion 
molecule intimin [Donnenberg and Kaper 1991], the intimin receptor Tir which is 
translocated into the host cells [Kenny et al., 1997] and other effector proteins 
[Jarvis et al., 1995]. Infection of the host cell requires a three-stage process [Don-
nenberg and Kaper, 1992]. During the first stage, pathogens adhere to the in-
testinal epithelium and form dense microcolonies [Baldini et al., 1983, Giron et 
al., 1991]. Among other pili, EPECs E. coli common pilus [Saldana et al., 2009], 
together with type IV bundle-forming pilus [Giron et al., 1991] and C. rodentiums 
colonisation factor [Mundy et al., 2003], are known to contribute to intestinal col-
onisation. During the second stage, pathogen adherence induces transduction 
of several signals in both, the host cell and the bacterium. In the bacterium, it 
stimulates the expression of LEE-encoded proteins and assembly of the pore 
forming T3SS [Knutton et al., 1998, Wolff et al., 1998]. This T3SS allows the 
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translocation of several effector proteins into the host cell, including intimin re-
ceptor Tir, which becomes inserted in host cell membrane [Wolff et al., 1998; 
Kenny et al., 1997]. In the host cell, adhesion increases the permeability of tight 
junctions and therefore fluid secretion [Manjarrez-Hernandez et al., 1996] and 
further enhances the calcium levels, leading to initial cytoskeletal changes [Bald-
win et al., 1991]. The third stage of infection is characterised by strong attach-
ment to the host cell, mediated by binding of the bacterial outer membrane pro-
tein intimin to its former translocated receptor Tir [Rosenshine et al., 1996]. This 
causes an amplification of cytoskeletal effects such as actin and myosin accumu-
lation as well as pedestal formation underneath the bacterium [Kenny et al., 1997] 
and colonic hyperplasia [Higgins et al., 1999].  
 
1.2. Course of C. rodentium infection in mice 
 
After oral challenge with C. rodentium, bacteria transit the bicarbonate rich stom-
ach to the site of colonisation in the intestine. Upon stimulation by bicarbonate 
[Yang et al., 2008], the key transcriptional regulator RegA activates virulence 
gene transcription and inhibits expression of housekeeping genes, in order to di-
rect bacterial energy towards production of virulence factors [Hart et al., 2008]. 
Colonisation starts in the caecal patch, the lympohoid tissue of the caecum [Wiles 
et al., 2004], although the caecum is neither required for general colonisation of 
the intestine nor for clearance [Steinhoff et al., unpublished data]. After three 
days, bacterial colonisation reaches the distal colon and peaks in parallel with 
development of colonic hyperplasia between day 5-14 post infection (p.i.) [Wiles 
et al., 2004]. Clearance proceeds in an analogous manner, starting in the cae-
cum, followed by the colon by day 21-28 p.i. [Wiles et al., 2004]. It is possible, 
that C. rodentium preferentially colonises sites, where it is easily recognised by 
the immune system because it possesses mechanisms, by which it can modulate 
the mucosal immune response in a so far unknown fashion [Mundy et al., 2005], 
comparable to EPEC [Klapproth et al., 2000, Celli et al., 2001]. Most mouse 
strains (C57Bl/6, NIH Swiss and Balb/c) show almost no mortality and C57Bl/6 
mice display the least mucosal hyperplasia [Barthold et al.,1977].  
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1.3. Immune response against C. rodentium 
 
Immune response to C. rodentium is a complex network comprising defence 
mechanisms of the adaptive as well as innate immune system.  
 
1.3.1. Innate immune system 
 
The innate immune system is a primary unspecific defence mechanism of the 
immune system. It involves the complement system and several immune cells 
like neutrophils, macrophages, mast cells, dendritic cells, natural killer cells, ba-
sophils, eosinophils and innate lymphoid cells. The major functions of the innate 
immune system include fast recognition and elimination of pathogens, as well as 
activation and recruitment of the adaptive immune system through antigen 
presentation and cytokine/ chemokine expression [Rivera et al., 2016].   
 
1.3.1.1. Toll-like receptors 
 
Toll-like receptors (TLR) belong to an evolutionarily conserved group of pattern 
recognition receptors (PRR) that recognise pathogen-associated molecular pat-
terns (PAMPs) and are expressed on many cell types like dendritic cells, phago-
cytes and endothelial cells [Roach et al., 2005]. PAMPs are structures, present 
among a wide range of bacteria, that allow a fast, unspecific recognition by the 
hosts immune system [Janeway and Medzhitov, 2002]. In mice 12 TLRs are de-
scribed. TLR1-6 and TLR11 are expressed on plasma membranes and interact 
with microbial membrane components, such as lipopeptides (TLR1, 2, 6) [Jin et 
al., 2007; Kang et al., 2009], lipopolysaccharides (TLR4) [Shimazu et al., 1999] 
and flagellin (TLR5) [Hayashi et al., 2001]. In contrast, TLR3 and TLR8-13 are 
localised in endosomal compartments and recognise microbial nucleic acids 
[Akira et al., 2006]. The binding of ligands to TLRs, initiates a signalling cascade, 
which recruits the TIR (Toll/IL-1R homology) domain-containing adaptor (TIRAP) 
[Yamamoto et al., 2002] and the myeloid differentiation primary response gene 
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88 (MyD88) to activate transcription factor nuclear factor kappa-light-chain-en-
hancer of activated B cells (NF-κB), resulting in expression of proinflammatory 
cytokines [Muzio et al., 1997]. 
 
1.3.1.2. Fcγ receptors 
 
The Fc-receptors which bind immunoglobulin G (FcγR) belong to a group of im-
munoglobulin gene superfamily, that bind to immunoglobulins by their Fc part and 
are expressed on several cells of the innate immune system, like neutrophils, 
monocytes, macrophages, dendritic cells, natural killer cells and B cells [Nimmer-
jahn and Ravetch 2008]. In mice, FcγRI, FcγRIIB, FcγRIII and FcγRIV are de-
scribed, all of which belong to the group of activating FcγRs, except for FcγRIIB, 
which belongs to the group of inhibitory FcγRs [Nimmerjahn and Ravetch 2006]. 
On most cells, inhibitory and activating FcγRs are co-expressed for optimal im-
mune regulation [Nimmerjahn and Ravetch 2006]. Further, they can be differen-
tiated into high and low affinity FcγRs, with respect to their binding affinity for 
Immunoglobulin subtypes [Nimmerjahn and Ravetch, 2008]. In mice, FcγRI has 
the greatest IgG binding affinity [Yoshida et al., 2006]. Upon receptor activation, 
FcγRs enhance phagocytosis, antibody-dependent cellular cytotoxicity and tran-
scription of proinflammatory cytokines [Dijstelbloem et al., 2001].  
For the defence against Citrobacter both, TLRs and FcγRs are required, as dele-
tion of TLR 2 in mice is lethal [Gibson et al., 2008] and deletion of FcγR affects 
bacterial elimination and increases lethality [Masuda et al., 2008] in mice. More-
over, MyD88 is crucial for TLR-mediated host defence against C. rodentium [Gib-
son, 2008] because it induces epithelial repair responses, expression of neutro-
phil-recruiting chemokines and activates adaptive immune responses with re-
spect to antibody secretion and thus opsonisation and finally clearance of the 
pathogen [Lebeis et al., 2007]. 
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1.3.1.3. Complement system 
 
The complement system is an evolutionary ancient part of the immune system, 
which is already found in ancient phyla like Cephalochordata [Suzuki et al., 2002] 
and Urochordata [Azumi et al., 2003], therefore it is considered as a component 
of the innate immune system. It consists of several proteins, that start a proteo-
lytic cascade upon activation through three different pathways, the classical, al-
ternative or lectin pathway [Dunkelberger and Song 2010]. Classical activation 
occurs when C1q, a part of the C1q-C1r-C1s-complex (C1) binds to IgG or IgM 
antigen-antibody complexes [Adu and Williams, 1983]. This results in autolytic 
activation of C1r, which activates C1s serin protease [Naff and Ratnoff, 1968]. 
C1s then cleaves C4 into C4a and C4b [Budzko et al., 1970], as well as C2 into 
C2a and C2b [Stroud et al., 1965]. Hereafter, C4b together with C2a form the 
enzyme C3 convertase, which then cleaves C3 into the anaphylatoxin C3a and 
the opsonin C3b [Budzko et al., 1971]. C3b together with C3-convertase form a 
C3b-C4b-C2a enzyme, which proteolytically cleaves C5 into anaphylatoxin C5a 
and C5b [Shin et al., 1968]. Anaphylatoxins C3a, C4a and C5a have a great pro-
inflammatory impact. Upon binding to receptors C3aR and C5aR [Gerard and 
Gerard 1994] they enhance recruitment of phagocytes [Ehrengruber et al., 1994] 
and phagocytic activity [Kretzschmar et al., 1993]. Finally, assembly of C5b with 
C6-9 generates a membrane attack complex (MAC), which forms pores in cell 
membranes and thus initiates cell lysis [Götze and Müller-Eberhard, 1970]. The 
lectin pathway is similar to the classical pathway, but differs in the first activation 
step. PRRs, like mannose-binding lectin (MBL), do not recognise antibody-anti-
gen complexes, but common carbohydrate PAMPs [Fujita et al., 2004]. Analo-
gous to C1 complex, MBL forms a complex with serin proteases (MASPs)-1, -2, 
and -3 [Takahashi et al., 2008], which cleaves C2 and C4 to generate C3 con-
vertase and finally MAC [Dunkelberger and Song, 2010]. The alternative path-
way uses an activation strategy without the participation of C1, C2 and C4 [Klein 
and Wellensiek, 1965]. Instead, C3 undergoes spontaneous hydrolysis into C3a 
and C3b and forms in presence of Factor D (Adipsin) and Factor B the C3 con-
vertase, which then cleaves C5 into C5a and C5b to generate MAC [Dunkel-
berger and Song, 2010].  
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For infections with C. rodentium the complement system is thought to be im-
portant, as C3-deficient mice show profound survival defects [Belzer et al., 2011]. 
Furthermore, complement component C3b enters the gut lumen and opsonises 
the enteropathogen for a more efficiant phagocytic uptake [Balzer et al., 2011]. 
 
1.3.1.4. Phagocytic cells 
 
Phagocytes are another part of the innate immune system, involved in defence 
against C. rodentium. Phagocytes can be divided into professional and non-pro-
fessional cells, depending on their phagocytic effectivity. The group of profes-
sional phagocytes involves leukocytes such as neutrophils, monocytes/ macro-
phages, mast cells and dendritic cells. They have special surface receptors, such 
as IgG binding FcγRs, which enable efficient binding and uptake of pathogens, a 
process called phagocytosis, followed by killing within the phagolysosome [Rab-
inovitch, 1995].  
Neutrophils 
Neutrophils, or polymorphonuclear neutrophilic leukocytes (PMN) are short-lived 
cells characterised by a segmented nucleus [Campbell et al., 1995]. They contain 
granules where antimicrobial proteins such as myeloperoxidases, defensins, lac-
toferrins and gelatinases are stored [Borregaard et al., 2007]. Under normal con-
ditions the majority of neutrophils is located in the bone marrow [Semerad et al., 
2002] and upon infection, their production and migration into the periphery is en-
hanced. Production of neutrophils is regulated by the number of apoptotic neu-
trophils, ingested by macrophages and dendritic cells (DCs). If the number of 
apoptotic neutrophils is low, these cells produce Interleukin-23 (IL-23), a cytokine, 
which stimulates IL-17 expression and therefore neutrophil development [Stark 
et al., 2005]. After development in the bone marrow, mature neutrophils migrate 
across the vascular barrier into blood vessels [Petrides and Dittmann, 1990]. 
Neutrophil migration 
Migration depends on the expression of granulocyte colony stimulating factor (G-
CSF), that influences the expression of chemokine receptor 4 (CXCR4) which is 
required for homing to the bone marrow and the chemokine receptor 2 (CXCR2), 
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necessary for neutrophil migration into blood vessels [Eash et al., 2010]. Migra-
tion into the blood system comprises the steps rolling, firm adhesion and transen-
dothelial migration [Kolaczowska and Kubes, 2013]. During rolling, Inflammatory 
mediators like IL-17 and tumor necrosis factor alpha (TNF-α) or PAMPs like LPS 
enhance the expression of endothelial P-selectin, E-selectin [Griffin et al., 2012] 
and integrins like intercellular adhesion molecules (ICAM) and vascular cell ad-
hesion protein (VCAM) [Radi et al., 2001]. Next, endothelial P-selectin and E-
selectin bind neutrophilic P-selectin/ligand 1 (PSGL-1) [Bruehl et al., 1997] to 
capture flowing neutrophils (tethering), and leukocyte L-selectin binds endothelial 
Glycosylation-dependent cell adhesion molecule-1 (GLYCAM1) [Bargatze et al., 
1994]. Slow rolling is an effect of continuous formation and breakage of such 
adhesive bonds [Ramachandran et al., 2004]. The activation of neutrophils, by 
binding of chemokines CXCL1, CXCL2 and CXCL5 to the receptor CXCR2 ena-
bles firm adhesion to the endothelium [Pruenster et al., 2009]. During this pro-
cess, neutrophil integrins LAF-1 (αLβ2) and Mac-1 (αMβ2) bind their ligands 
ICAM-1, ICAM-2 and VCAM-1 on activated endothelial cells [Bunting et al., 2002; 
Zaher et al., 2001]. Transendothelial migration requires again ICAM-1, ICAM-
2, VCAM1, integrins LFA-1 and MAC-1, as well as several junctional and adhe-
sion proteins [Barreiro et al., 2008]. Transmigration may either occur between 
endothelial cells (paracellular) or through transcellular transition (transcellular) 
[Kolaczkowska and Kubes, 2013]. During paracellular transmigration, ICAM-1 in-
directly destabilises cadherin bonds and therefore loosens endothelial cell-cell-
junctions [van Buhl et al., 2007]. Moreover, ICAM-2 guides neutrophils to cross 
the endothelial barrier by entering cell junctions [Woodfin et al., 2009]. Less pre-
ferred and less efficient is the transcellular pathway [Phillipson et al., 2008]. Here, 
the endothelial cells form in an ICAM-1- and VCAM-1-dependent manner dome-
like structures [Barreiro et al., 2002]. After leaving the vascular system, multiple 
chemokine gradients like CXCL2 [Quinton et al., 2004] and anaphylatoxins [Fox-
man et al., 1997] guide neutrophils through the interstitium to the site of inflam-
mation. In case of C. rodentium infection, neutrophils have to reach the intestinal 
lumen [Kamada et al., 2015]. To reach the lumen, PMNs need to cross the epi-
thelial cell border. Although transepithelial migration (TEM) of PMN is incom-
pletely understood, differences and similarities to transendothelial migration are 
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known [Brazil and Parkos, 2016]. The process of TEM consists also of initial ad-
hesion, migration through cells and postmigratory events. Adhesion occurs here 
at the basolateral epithelial surface [Parkos, 1997] and can be increased by in-
flammatory mediators like TNF-α [Miyata et al., 1999] and Interferon gamma 
(IFN-γ) [Colgan et al., 1993]. After adhesion, neutrophils cross the intestinal epi-
thelium in a MAC-1-dependent, but LFA-1-independent manner to reach the in-
testinal lumen [Parkos et al., 1991]. The paracellular, luminal migration increases 
upon cytokine-induced expression of ICAM-1, the ligand of MAC-1, on the luminal 
(apical) epithelial membrane [Sumagin et al., 2014].  
Neutrophil phagocytosis, Degranulation and NETs formation 
After reaching sites of inflammation, PMNs use three mechanisms to kill patho-
gens: Phagocytosis, Degranulation and neutrophil extracellular trap (NET) for-
mation [Kolaczkowska et al., 2013]. Phagocytosis is a receptor mediated pro-
cess of an actin-dependent internalisation of microorganisms, cells or environ-
mental debris (>0,5µm) [Flannagan et al., 2012]. The involved receptors are ei-
ther TLRs which recognise PAMPs, FcγRs recognising IgG-opsonised pathogens 
or CRs recognising complement-opsonised pathogens [Flannagan et al., 2012]. 
Binding of receptors to pathogens causes receptor-clustering, induction of signal 
cascades and finally, actin-dependent engulfment into a phagosome [Flannagan 
et al., 2012]. The phagosome by itself is inert, i.e. unable to kill or digest its con-
tent. The fusion of phagosomes with lysosomes leads to the formation of a phag-
olysosome which is highly acidic and enriched with microbicidal enzymes [Hamp-
ton et al., 1998]. Further, the enzyme nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase generates reactive oxygen species (ROS), like superox-
ide anions (O2-) and hydrogenperoxides (H2O2), known as respiratory/ oxidative 
burst, which finally kill the bacteria [Borregaard and Cowland, 1997]. Degranula-
tion or exocytosis is the release of mediators from granules [Sheshachalam et 
al., 2014]. This step involves granule translocation via microtubule assembly and 
actin remodelling, as well as vesicle docking at the plasma membrane via SNARE 
proteins, and finally fusion of vesicle and membrane [Lacy and Eitzen, 2008]. The 
released content includes bactericidal lactoferrin, matrix metalloproteases, 
myeloperoxidase (MPO) and elastase [Sheshachalam et al., 2014]. NETs are 
9 
 
extracellular fibres, composed of granules, DNA and elastase, formed to kill bac-
teria [Brinkmann et al., 2004]. Stimulation of neutrophils with IL-8, LPS or other 
bacterial components initiates a cell death cascade, resulting in the release of 
NETs [Brinkmann and Zychlinsky 2007]. Beside these three mechanisms, neu-
trophils secrete proinflammatory mediators to recruit other immune cells [Manto-
vani et al., 2011], prime CD4+ T helper cells (TH) by lowering their activation 
threshold [Tillack et al., 2012] and promote IgG secretion via B cell activation 
[Kolaczkowska and Kubes, 2013]. During infection with C. rodentium the CXCR2 
dependent neutrophil influx was shown to be crucial for host defence [Spehlmann 
et al., 2009]. 
Monocytes, inflammatory monocytes and macrophages 
Monocytes, inflammatory monocytes and macrophages are professional phago-
cytic cells. The gut contains multiple types of macrophages, which are difficult to 
characterise and differentiate [Murray and Wynn, 2011]. Upon infection, circulat-
ing blood monocytes migrate as inflammatory monocytes into inflamed tissues 
and differentiate into macrophages [Shi and Pamer, 2011]. Inflammatory mono-
cytes and activated macrophages secrete antimicrobial nitric oxide, proinflamma-
tory mediators like TNF and IL-1, as well as IL-12 and IL-23, both required for 
TH1 and TH17 polarisation, respectively [Murray and Wynn, 2011]. For this rea-
son, they are involved in host defence against C. rodentium [Kim et al., 2011]. 
 
1.3.2.  Adaptive Immune system 
 
If the innate immune response is not able to clear bacterial infections, the adap-
tive immune system is activated, which recognises the pathogen in a specific 
manner. It is composed of highly specialized cells, like B and T cells which will 
give rise to the immunological memory. The specificity of the adaptive immunity 
is determined by specific antigen-receptors which undergo somatic hypermuta-
tion during the course of infection, leading to increased affinity and virtually un-
limited specificities of antigen receptors [Boehm, 2011].  
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1.3.2.1. T cells 
 
T cells originate from thymus, from where they enter the bloodstream and circu-
late between peripheral lymphoid tissues and blood system [Marrack, et al., 
1988]. Upon activation by antigen-presenting cells, naïve T cells proliferate and 
differentiate to effector T cells [von Andrian and Mackay, 2000]. Different sub-
types of T cells are known and especially CD4 positive T helper cells (TH1 and 
TH17) are important for immune responses against extracellular bacteria, such 
as C. rodentium [Higgins et al., 1999; Wang et al., 2014]. TH1 cells secrete IFNγ 
and thus activate macrophages which show enhanced phagocytic activity [Lya-
dova and Panteleev, 2015]. Further, they promote clonal expansion of B cells and 
antibody production [Smith et al., 2000]. TH17 cells mainly produce IL-17 [Park 
et al., 2005] and additionally secrete cytokines like IL-22, IL-26 and granulocyte-
macrophage-CSF(GM-CSF) [Lyadova and Panteleev, 2015]. IL-17 is crucial for 
neutrophil recruitment, as well as inflammation [Zambrano-Zaragoza et al., 2014]. 
Together with TNF-α, IL-17 influences endothelial cells [Griffin et al., 2012] and 
intestinal epithelial cells [Zhang et al., 2015] to produce neutrophil-attracting 
chemokines, such as CXCL1, CXCL2 and CXCL5. This synergistic effect pro-
motes expression of P-selectin, E-selectin [Griffin et al., 2012] as well as ICAM-
1 [Albanesi et al., 1999] to enable neutrophil migration. Several cells, like TH17 
cells, regulatory T cells (Treg), natural killer (NK) cells, mast cells [Adami et al., 
2014], macrophages [Song et al., 2008] and innate lymphoid cells (ILCs) [Sutton 
et al., 2012] are known to produce IL-17. However, the main source of IL-17, that 
contributes to neutrophil mediated defence against C. rodentium are TH17 cells 
[Ishigame et al., 2009]. 
 
1.3.2.2. B cells  
 
B cells are another cell type of the adaptive immune system, important for hu-
moral immune responses. They mature in the bone marrow, from where they 
migrate to secondary lymphoid organs [Kondo, 2010]. Characteristically, B cell 
express highly specific immunoglobulin receptors, called B cell receptors (BCRs) 
on the cell surface [Lam et al., 1997]. In naïve mature B cells a process called 
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V(D)J recombination rearranges variable (V), joining (J) and diversity (D) gene 
segments and enables thereby the expression of class IgM and IgD antibodies 
with diverse antigen binding sites [Brack et al., 1978]. Antigen binding to these 
receptors leads to B cell activation, followed by antigen internalisation and 
presentation via major histocompatibility complex (MHC II) to T cells [Parker, 
1993]. B cells differentiate into antibody-secreting plasma cells through the inter-
action with T cells, and undergo a mechanism called class switching. Class 
switching does not influence antigen specificity because it does not change the 
variable region but only the constant (C) region of the antibody heavy chain. This 
allows the plasma cell to switch between the production of different antibody iso-
types, such as from IgM to IgG and therefore enables expression of antibody 
classes IgA, IgE and IgG [Shimizu and Honjo, 1984]. Immunoglobulins protect 
the host from infections by three mechanisms i.e. neutralisation, opsonisation and 
complement activation. Antibodies neutralise a pathogen, for instance by binding 
and masking structures involved in adhesion, therefore inhibiting the infectivity 
[Klasse and Sattentau, 2002]. Further, bound antibodies opsonise pathogens 
and therefore mark them for uptake by phagocytic cells [Flannagan et al., 2012]. 
Last not least, antibodies bound to pathogens can activate the complement 
system, leading to opsonisation and bacterial lysis [Adu and Williams, 1983]. 
Different antibody classes allow different effector functions, but remarkably for 
eradication of C. rodentium, only IgG was shown to be crucial because IgG-defi-
cient mice are unable to clear infection [Maaser et al., 2004].  
 
1.3.3.  Commensal microbiota 
 
Commensal microbiota comprises all microorganisms, which are present on body 
surfaces that are exposed to external environment, such as the gastrointestinal 
and respiratory tract [Tlaskalova-Hogenova et al., 2004]. The mammalian intesti-
nal system is colonised by 1000-5000 different bacterial species [Qin et al., 2010]. 
Co-evolution developed a system of mutualism, in which the host provides nutri-
ents and habitat, whereas the microbiota stimulates the immune system, pre-
vents harmful bacterial colonisation, and produces immunorecative substances, 
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such as short chain fatty acids (SCFAs) and vitamins [Hooper et al., 2010]. Infec-
tion of germ free (GF) mice (mice without bacteria) with C. rodentium illustrates 
the importance of commensal bacteria because these mice are unable to clear 
infection until association with gut microbiota [Kamada et al., 2012].  
 
1.3.3.1. Direct bacterial competition 
 
Bacterial competition is an important defence mechanism to avoid pathogen ad-
herence to epithelial cells. Nutrient availability and space are limiting factors in 
the intestinal ecosystem, resulting in diverse bacterial species, with a distinct met-
abolic profile, specialised in efficient uptake of distinct nutrients [Kamada et al., 
2013]. For this reason, commensal bacteria like E. coli are highly specialised on 
monosaccharide uptake and thus can outcompete metabolically related patho-
gens like C. rodentium. Therefore, association with E. coli decreases pathogen 
burden, but does not initiate sterile clearance [Kamada et al., 2012; Steinhoff et 
al., unpublished data].   
 
1.3.3.2. Impact of commensal bacteria on neutrophil migration 
 
Despite direct competition, gut microbiota also influences the adaptive immune 
system with respect to neutrophil migration. Commensal bacteria like segmented 
filamentous bacteria (SFB) promote generation of TH17 cells in mice, the main 
source of proinflammatory IL-17A in the intestine [Ivanov et al., 2009], known to 
induce neutrophil-attracting CXCL2 [Zhang et al., 2015]. CXCL2 itself, was shown 
to be upregulated in a MyD88-dependent manner, upon commensal colonisation, 
leading to increased numbers of neutrophils in periodontal tissues [Zenobia et al., 
2013]. Furthermore, bacterial propionate and acetate were shown to enhance 
neutrophil chemotaxis [Vinolo et al., 2011]. Last, bacteria or bacterial components 
such as LPS are known to enhance ICAM-1 expression by colonic epithelial cells, 
resulting in increased neutrophil transmigration [Huang et al., 1996].  
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1.3.3.3. Impact of commensal bacteria on phagocyte activity 
 
Besides these migratory effects, the microbiota stimulates phagocytic activity 
[Morland and Midvedt, 1984] and oxidative burst [Mittrücker et al., 2014]. Not only 
living bacteria, but also bacterial components where shown to enhance phago-
cytic activity, as well as oxidative burst [Vinolo et al., 2011]. Further, lack of com-
mensal bacteria reduces number of B cells and IgA levels in the intestine and 
therefore reduces phagocytic uptake of pathogens [Kamada et al., 2013]. 
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2. Materials 
 
2.1. Mouse and bacterial strains 
 
Strain      Origin 
C57BL/6N     Charles River Laboratories 
C57BL/6N germ free Biomedical Research Centre of Philipps-
University Marburg, Institute for Medical Mi-
crobiology and Hospital Hygiene, Prof. 
Steinhoff, Germany 
Il-17a/f-/- Prof. Immu Prinz, Institute of Immunology, 
Hannover Medical School, Germany 
C3-/- Prof. Admar Verschoor, Institute of systemic 
inflammations, Lübeck 
C5-/- Prof. Admar Verschoor, Institute of systemic 
inflammations, Lübeck 
C5+/- Prof. Admar Verschoor, Institute of systemic 
inflammations, Lübeck 
 
C. rodentium DBS 100 (NA-resistant) Biomedical Research Centre of Philipps-
University Marburg, Institute for Medical Mi-
crobiology and Hospital Hygiene, Prof. 
Steinhoff, Germany 
2.2. Reagents 
 
Reagents     Company 
Agar Roth, Germany 
Ammonium chloride (NH4Cl) Sigma-Aldrich, Germany 
Bovine serum albumin standard (BSA) Sigma-Aldrich, Germany  
Brefeldin A Sigma-Aldrich, Germany 
Easycoll (Percoll) Biochrom AG, Germany 
Eosin Merck, Germany 
Ethanol 96% Sigma-Aldrich, Germany 
Ethylenediaminetetraacetic acid (EDTA) Promega, USA 
FACS clean & rinse BD Bioscience, Germany 
Fetal calf serum (FCS) Gibco, USA 
Formaldehyde 36,5% Sigma-Aldrich, Germany 
Gentmicin Roth, Germany 
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H20 (deionised) B Braun, Germany 
Halt Protease Inhibitor Sinngle-Use  Thermo F. Scientific, Germany 
Cocktail (100x) 
Hank´s Balanced Salt Solution PanBiotech, Germany 
(HBSS) 
Haemaulan (Mayer) Merck, Germany 
HeparinNatrium 25.000 Ratiopharm, Germany 
Histopaque 1,119 Sigma-Aldrich, Germany 
Hoechst 33258 Sigma-Aldrich, Germany 
Ionomycin Sigma-Aldrich, Germany 
Isofluran Baxter, Germany 
Isopropanol Roth, Germany 
LB-Broth Base Gibco, Germany 
L-Glutamine Biochrom AG, Germany 
MEM non-essential amino acids PAA, Austria 
Nalidixic acid AppliChem, Germany 
Penicillin G Biochrom AG, Germany 
4-(2-hydroxyethyl)-1-piperazineethano- Roth, Germany 
Sulfonic acid (HEPES) 
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich, Germany 
Phosphate buffered saline (PBS) Biochrom AG, Germany 
Saponin Sigma-Aldrich, Germany 
Sodium hydrogen carbonate (NaHCO3) Sigma-Aldrich, Germany 
Sodium chloride (NaCl) Sigma-Aldrich, Germany 
Streptomycin Biochrom AG, Germany 
Thioglycollate Thermo F. Scientific, Germany 
Tissue optimal cutting compound Q path, VWR chemicals, France 
Tris Base Roth, Germany 
Tris-HCl Roth, Germany 
Tri reagent Sigma-Aldrich, Germany 
Triton-X 100 Sigma-Aldrich, Germany 
Trypan blue Gibco, Germany 
Tween 20 EMD Chemicals, Germany 
β-Mercaptoethanol Sigma-Aldrich, Germany 
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2.3. Media, buffers and solutions 
 
Buffer Composition 
Balanced salts solution (BSS) 9,9 g/L BSS, 17 mM NaHCO3, 10 mM 
HEPES, in sterile H2O 
Bovine serum albumin standard (BSA) 1 mg of BSA in 1 mL sterile H2O 
Cell culture coating buffer (pH 9,5) 50 mM Tris-Base in sterile H2O 
ELISA blocking buffer 3% BSA [v/v] in 1 x PBS 
2% Formaldehyde 2% Formaldehyde in 1 x PBS 
Gentamicin medium 10% FCS [v/v], 0,4 mM L-Glutamin, 1 mg 
Gentamicin in RPMI 1640 medium 
HBSS prep 0,5% FCS [v/v], 20 mM HEPES in 1 x PBS 
LB agar 7,5 g Agar powder in 500 mL LB medium 
LB medium 20g LB-powder in 1L distilled water  
LB medium/ agar with NA 100 µL NA solution in 100 mL LB medium 
MACS buffer (pH 8,0) 0,5% BSA [w/v], 2 mM EDTA in 1 x PBS 
NaCl 0,2%/ 1,6% 0,2/ 1,6% [v/v] NaCl in distilled Water 
NA solution 500 mg NA in 10 mL 1 x PBS, with 1M NaOH 
1 x PBS/ 1% FCS 1% FCS [v/v], in 1 x PBS 
1 x PBS 10% 10 x PBS [v/v] in sterile H2O 
Saponin buffer 0,3% saponin [w/v], 2% FCS [v/v] in 1x PBS 
Roswell Park Memorial Institute medium 10% FCS [v/v], 50 µM β-mercaptoethanol, 
30 
(RPMI complete medium) mg/mL penicillin G, 50 mg/mL streptomycin 
in RPMI-1640 
 
2.4. Enzymes 
 
Enzymes Company 
Collagenase D Roche, USA 
Collagenase VIII Sigma-Aldrich, Germany 
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2.5. Antibodies 
 
ELISA antibodies Origin    Use 
Goat α-mouse-IgG Southern Biotech  1:4.000 
 
FACS antibodies            Origin     Use 
α-mouse-CD4-PE eBioscience    1:500 
α-mouse-CD8a-PE eBioscience    1:500 
α-mouse-CD8b-PE BD Biosciences   1:500 
α-mouse-CD11b-FITC                           eBioscience    1:200 
α-mouse-CD34-FITC Pharmingen    1:200 
α-mouse-CD335-APC BioLegend    1:500 
α-mouse-F4/80-APC eBioscience     1:500 
α-mouse-IL-17A-APC eBioscience     1:500 
α-mouse-IL-17A-PE eBioscience     1:500 
α-mouse-IL-17F-PE eBioscience     1:500 
α-mouse-Ly6C-APC                               eBioscience    1:500 
α-mouse-Ly6G-PE                             eBioscience     1:800 
 
MACS antibodies/ substances Origin     Use 
α-FITC-Streptavidin Caltag, UK    1µL  
Micro Beads, Nanomag-CLD  Micromod, Germ any   50µL 
300nm NH2     
α-mouse-Ly6G-FITC BioLegend, USA   1µL  
  
Histology antibodies Origin     Use 
Hamster α-mouse-CD54-FITC Pharmingen    1:500 
Goat α-FITC-Alexa488 Invitrogen    1:500 
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2.6. Depleting substances 
 
Substance Origin 
Dichloromethylene bisphosphate ClodronateLiposomes, Netherlands 
(Clodronate-Liposomes) 
NIMP-R14 Dr. Friederike Jönsson, Institut Pasteur, Pa-
ris 
RB6-8C5 Dr. Friederike Jönsson, Institut Pasteur, Pa-
ris 
 
2.7. Kits 
 
Kit Origin 
RevertAid First Strand cDNA Synthesis kit Thermo F. Scientific, USA 
RNeasy Mini Kit Qiagen 
ELISA Mouse IL-17 DuoSet R&D Systems, USA 
 
 
2.8. Primers 
 
Primers murine 5´-3´sequence 
cxcl1          fwd     GCT TGA AGG TGT CCT CAG 
                  rev      AAG CCT CGC GAC CAT TCT TG 
cxcl2          fwd      TTT GAC CGC CCT TGA GAG TG 
                  rev       CAT CCA GAG CTT GAC GGT GAC 
cxcr2         fwd       GCA GGT GCT CCG GTT GTA TAA 
                  rev       TCT CTC AGG AAA TGC CAC CC 
hprt1          fwd CTG GTG AAA AGG ACC TCT CG 
                  rev TGA AGT ACT CAT TAT AGT CAA GGG 
CA 
il-17a         fwd TTT AAC TCC CTT GGC GCA AAA 
                  rev CTT TCC CTC CGC ATT GAC AC 
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2.9. Consumables 
 
Name                                           Type                                     Origin 
Cannulas 
Cell culture plates 
Centrifuge tubes 
Clean Bench 
Cooling centrifuges 
 
Cover glass 
Cryomold spec. block 
ELISA plates 
ELISA reader 
Flow Cytometer 
Glass pipettes 
Hemocytometer 
Homogeniser 
Incubator 
Inoculation loop 
Laminar Air Flow 
Latex gloves 
MACS Multistand 
Magnetic sep. rack 
Magnetic stirrer 
Micro scales 
Microscope light 
Microscope 
Laser-scan-confocal 
Microcentrifuge tubes 
Object slide 
PCR reaction tubes 
PCR machine 
Petri dishes 
pH meter 
24G, 26G 
24/ 96-well 
15/ 50 mL 
HERAsafe 
Megafuge 1,0R 
Microcentrifuge 
Menzel, 24 mm x 50 mm 
15 mm x 15 mm x 5 mm 
96 Micro-well 
FLUOstar 
BD FACSCalibur 
Precicolor 5/ 10/ 25 mL 
Neubauer 0,1 mm 
UltraTrray T10 
HerAcell 240 
10 µL, sterile 
HERAsafe Typ 18 
Vasco nitril white 
QuadroMACS 
MagneSphere 
RH basic 
Explorer Pro 
DFC 480 
TCS2, TCS5 
 
0,5/ 1,5/ 2 mL 
Menzel, Sup.frost+Gold 
0,2 mL attach. Cap 
Personal cycler/gradient    
90 x 16 mm 
InoLab pH Level2 
BD Microlance, G. 
Cellstar, Germany 
BC Falcon, Germany 
Heraeus, Germany 
Heraeus, Germany 
Roth, Germany 
Weckert, Germany 
Tissue- Tek, Japan 
Nunc, Germany 
BMG Labtech, Germany 
BD Bioscience, G. 
HBG, Germany 
Hecht Assistant, G. 
IKA, Germany 
TF Scientific, G. 
Sarstedt, Germany 
Kendro Lab., Germany 
Braun, Germany 
Miltenyi, Germany 
Promega, USA 
IKA, Germany 
OHAUS, Switzerland 
Leica, Germany 
Leica, Germany 
 
Sarstedt, Germany 
Greiner bio-one, G. 
Greiner bio-one, G. 
Biometra, Germany 
Sarstedt, Germany 
Biorad, Germany 
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Pipettes 
Pipette-controller 
Power Supply 
Multi pipette 
Nylon cell strainer 
qRT-PCR cycler 
qRT-PCR plate 
RNase free tubes 
Rotator 
Scale 
Shaker 
Spectrophotometer 
Sterile filter 
Syringe 
Thermo block 
Vortex mixer 
 
 
 
10/ 100/ 1000 µL 
Accu-jet pro 
Power Pac 1.000 
50 µL 
70/ 100 µM filter 
TagMan StepOne 
96 Fast PCR half skirt 
Biosphere safe-seal 
Bio RS-24 (PRS-22) 
Adventurer pro 
Gyrotory Shaker G2 
Nanodrop ND-1.000 
0, 22 µm 
1/ 10 mL 
Thermostat TCR2.000 
Lab dancer, MS1, MS3 
 
 
 
Eppendorf AG, G. 
Brand, Germany 
Biorad, Germany 
TF Scientific, G. 
Corning, USA 
Life Technologies, USA 
Sarstedt, Germany 
Sarstedt, Germany 
BIOSAN, Latvia 
Ohaus, USA 
N Brunswick Sc., USA 
Peqlab, Germany 
Millex, Germany 
BD Bioscience, G. 
Roth, Germany 
IKA, Germany 
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3. Methods 
 
3.1. Mice maintenance and breeding 
 
C57BL/6N mice were purchased from Charles River Laboratory and kept in the 
animal facility of the Biomedical Research Centre of Philipps-University Marburg. 
Il-17a/f-/- mice were kindly provided by Prof. Immo Prinz, Institute of Immunology, 
Hannover Medical School, Germany. C3-/-, C5-/- and C5+/- mice (on C57BL/6N 
background) were kindly provided by Prof. Admar Verschoor, Institute of systemic 
Inflammations, Lübeck. All mice were housed under standard specific-pathogen 
free animal facility conditions, with 12 h light cycle, standard rodent pellet diet and 
water ad libitum. GF mice (on C57BL/6N background) were bred in sterile isola-
tors in the animal facility of the Biomedical Research Centre of Philipps-University 
Marburg and kept under sterile conditions. All experiments were carried out in 
accordance with the animal ethics approved by R.P. Giessen, Germany. Mice 
were sacrificed by cervical dislocation or isoflurane.  
 
3.2. Infections with C. rodentium 
 
3.2.1.  Cultivation of C. rodentium 
 
The microbial strain of C. rodentium was plated on LB-agar, containing nalidixic 
acid (50 µg/ mL) and incubated overnight (ON) at 37°C. A single colony was 
transferred to a conical flask containing 100 mL LB media and nalidixic acid (50 
µg/ mL) and incubated ON at 37°C and 150 rpm on a shaker.   
 
3.2.2.  Preparation of gavage suspension 
 
100 mL of C. rodentium-ON culture was centrifuged for 20 min at 4.000 rpm and 
4°C. Supernatant was discarded and pellet resuspended in 10 mL of sterile PBS. 
200 µL was administered orally by gavage to each mouse.  
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3.2.3.  CFU determination in stool samples 
 
Stool samples were collected from infected mice, weighed and homogenised in 
100 µL PBS/ 10 mg stool. Serial dilutions were performed, starting with 10 µL of 
sample or 10 µL of gavage suspension, that was transferred in a well containing 
90 µL PBS and mixed thoroughly. From this 1:10 dilution again 10 µL was trans-
ferred in another well containing 90 µL PBS and mixed thoroughly. This proce-
dure was repeated 8-11 times, dependent on bacterial numbers. 10 µL of each 
dilution step was plated on LB-agar containing nalidixic acid (50 µg/ mL) and in-
cubated ON at 37°C. For CFU (colon forming unit) determination, colonies were 
counted, multiplied with the number of dilution step and multiplied with 1.000. 
 
3.2.4.  Microbiota transplantation 
 
Three days p.i. the caecal and colonic content of a SPF mouse was collected, 
weighed and homogenised with PBS (200 µL PBS/ 10 mg stool). 200 µL of this 
suspension was administered orally to each mouse.  
  
3.3. Application of RB6-8C5 and NIMP-R14 neutrophil-depleting an-
tibodies  
 
RB6-8C5 and NIMP-R14 antibodies were diluted in PBS and a total amount of 
500 µg were injected on day 5, 8, 11, 14 and 16 p.i. i.v.. RB6-8C6 binds to and 
opsonises Ly6G+ neutrophils, whereas NIMP-R14 binds in addition Ly6Chigh+ 
cells and opsonises not only neutrophils, but also inflammatory monocytes for 
instance. 
 
3.4. Application of macrophage-depleting clodronate  
 
200 µL of clodronate suspension was mixed thoroughly and administered to each 
mouse i.p.. Injection started on day 8 p.i. and was repeated every two days until 
the experiment was terminated. In general, clodronate liposomes are not toxic. 
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However, after uptake by macrophages the liposome phospholipid bilayer gets 
disrupted by enzymes of the phagolysosome and clodronate is released into the 
cell, where it accumulates and initiates apoptosis. After cell death, clodronate is 
released and quickly gets removed from the circulation [van Rooijen et al., 1996]. 
 
3.5.  Histology 
 
One cm piece of colon was placed inside of a 15 mm x 15 mm x 15 mm cryomold 
specimen block, which was filled immediately with tissue optimal cutting temper-
ature compound. This block was then flash frozen using 2-methylbutane and liq-
uid nitrogen and stored at -80°C until use. 
 
3.5.1.  HE-staining 
 
HE-staining is used for overview stainings since nuclei are stained blue whereas 
cytoplasm is stained red. For HE staining 3-5 µm colonic cryosections were 
stained for 5 min with hematoxylin, washed with water and incubated for 15 min 
with eosin, followed by incubation in 80% ethanol for 2 h, 30 secs incubation in 
96% ethanol, 5 min incubation in isopropanol and finally 5 min incubation in each, 
xylol1 and xylol2. After drying for 24 h, slides were examined using bright field 
microscopy. 
 
3.5.2.  Immunochemistry 
 
Immunochemistry is used to label and visualise specific antigens with fluoro-
chrome-linked antibodies, in histological sections. For immunochemistry 3-5 µm 
colonic cryosections were washed 3 x for 5 min with PBS and incubated with 50 
µL of 1:500 diluted α-mouse-CD54-FITC primary antibody for 2 h at room tem-
perature. After repeating the washing step, 50µL of 1:500 diluted α-FITC second-
ary antibody was added and samples were incubated for 1 h at room temperature, 
before transferring them to aqua dest. and coating them with mowiol. Finally, 
slides were dried for 24 h at 4°C and examined using confocal microscopy. 
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3.6. Cell isolation techniques 
 
3.6.1.  Isolation of colonic immune cells 
 
Since the extracellular pathogen C. rodentium is located in the intestine, studies 
of the immune cells in the colon are essential for understanding the ongoing im-
mune response against the enteropathogen in the gut. For this purpose, intraep-
ithelial and lamina propria cells were enriched from colon, using a previously de-
scribed method [Visekruna et al., 2015]. In brief, colon was cut longitudinally and 
washed with PBS to remove faeces. This colon was then transferred into a 50 
mL centrifuge tube containing 25 mL RPMI complete medium and incubated for 
30 min at 37°C and 150 rpm on a shaker to loosen epithelial cells. Afterwards, 
the tube was shaken for 20 secs by hand in order to release the loosened epithe-
lial cells into the medium. This medium was then filtered through a 100 µm filter 
to exclude bigger tissue particles and stored on ice until usage. The colonic tissue 
was cut into very small pieces, transferred to a 50 mL centrifuge tube containing 
25 mL digestion medium and incubated for 40 min at 37°C and 150 rpm on a 
shaker to digest collagen and release immune cells from lamina propria into the 
medium. After incubation, the tube was shaken 20 sec by hand in order to release 
the loosened lamina propria cells into the medium. This medium was then filtered 
through a 100 µm filter to exclude bigger tissue particles. All centrifuge tubes 
were centrifuged at 1.500 rpm and 4°C for 5 min to pellet the immune cells. The 
supernatant was discarded and the pellet resuspended in 2,5 mL of 30% (for 
neutrophil isolation) or 40% (for T cell isolation) percoll, which was diluted in RPMI 
complete medium. The intraepithelial and lamina propria fractions were then 
pooled and layered over 3 mL of 70% percoll, diluted in RPMI complete medium 
and centrifuged at 2.000 rpm and 23°C for 20 min without break, in order to form 
a density gradient to separate immune cells from debris. The interphase contain-
ing immune cells was carefully collected, transferred to a 15 mL centrifugation 
tube and centrifuged at 1.500 rpm and 4°C for 5 min to pellet the immune cells. 
Last, the cells were resuspended in 1 mL RPMI complete medium, counted, 
stained and used for flow cytometry.   
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3.6.2.  Isolation of neutrophils from bone marrow using MACS 
 
The bone marrow is the reservoir of neutrophils, from where they are released 
into the blood and to sites of infection [Petrides and Dittmann, 1990]. To obtain a 
highly purified neutrophil culture which is required for qRT-PCR, neutrophils were 
isolated from bone marrow. For this purpose, femur and tibia from both murine 
legs were excised, ends were cut sterile and bone marrow was flushed with RPMI 
+ 2% FCS in a 50 mL centrifuge tube, using a 24-gauge needle and 10 mL sy-
ringe. After centrifugation at 1.300 rpm and 4°C for 5 min, the supernatant was 
discarded and the pellet resuspended in 20 mL MACS buffer and filtered through 
a 70 µm filter into a new 50 mL centrifuge tube for following positive magnetic cell 
separation (MACS).  
MACS is a method for the isolation of a defined cell population based on its sur-
face antigens. In brief, a FITC-coupled antibody is added to the cell mix. This 
antibody binds to cells with a specific surface antigen, in case of neutrophils to 
Ly6G. Hereafter, a second streptavidin-coupled antibody is added, which directed 
against FITC from the former antibody. Next, biotinylated nanobeads are added, 
which bind to streptavidin. Finally, the cell-antibody-bead-complex bind to the 
magnetic column and the non-bound cells can be discarded. For this method, the 
cell-mix-pellet was resuspended in a 15 mL centrifuge tube in 250 µL MACS 
buffer, 0,5 µL α-mouse-Ly6G-FITC antibody was added and cells were incubated 
for 10 min at 4°C. Cells were washed with MACS buffer, resuspended in 100 µL 
MACS buffer and 1 µL combi-α-FITC-streptavidin-antibody was added. After an 
incubation of 15 min at 4°C, cells were washed twice with MACS buffer, resus-
pended in 1,5 mL MACS buffer and transferred to 1,5 mL plastic tubes. Then, 50 
µL biotin-beads were added and incubated for 15-20 min at 4°C on a rotator. 
Afterwards, the tube was placed on a magnetic column for 15 min at RT. After 
the incubation, the supernatant was removed, new 1,5 mL MACS buffer was 
added and the tube was again placed on the magnetic column. This step was 
repeated three times for optimal purity.  
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3.6.3.  Isolation of neutrophils from blood 
 
Compared to bone marrow, less neutrophils are present in the blood, which are 
even outnumbered by erythrocytes that can interfere with flow cytometric anal-
yses. For neutrophil isolation, murine blood was obtained from heart, added to 1 
mL HBSS prep, which was supplemented with 80 µL heparin (25 I. E./ mL) and 
layered on 3 mL of 1,119 histopaque. Density gradient centrifugation was per-
formed by centrifugation for 5 min at 300 x g and 23°C, followed by 20 min at 800 
x g and 23°C without break. An erythrocyte-containing pellet and a neutrophil-
containing interphase were visible. This interphase was collected into a 15 mL 
centrifuge tube and washed with PBS/ 1% FCS. After centrifugation at 1.500 rpm 
and 4°C for 5 min, the pellet was resuspended in 1 mL of ice cold 0,2% NaCl. 
After 20 secs, 1 mL of ice cold 1,6% NaCl was added and the tube was filled with 
PBS/ 1% FCS. Hereafter, the cells were washed three times with PBS/ 1% FCS 
to remove the lysed erythrocytes, which are more susceptible to hypotonic solu-
tions than neutrophils.  
 
3.6.4.  Isolation of peritoneal neutrophils (thioglycolate induced) 
 
For induction of sterile peritonitis, 1,5 mL of 3% thioglycolate was injected i.p.. 
After 4 h incubation, the peritoneum was flushed with 10-15 mL warm RPMI com-
plete medium using a syringe. The hereby isolated cells were filtered through a 
100 µm filter and collected in a 50 mL centrifuge tube, which was then centrifuged 
at 400 x g and 23°C for 10min. Cells were resuspended in 1 mL of RPMI complete 
medium and counted, prior to analysis with flow cytometry. 
 
3.6.5. Flow cytometry 
 
Flow cytometry is a method to characterise cells for their surface markers, intra-
cellular cytokine production or transcription factor expression. During analysis, 
single cells can be identified due to their light-emitting profile. Forward-scattered 
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light provides information about cell size and side-scattered light about cell gran-
ularity. Antibody-coupled fluorochromes are used to label cell antigens specifi-
cally by their light-emitting profile and visualise them using flow cytometry.  
For flow cytometry, cells were transferred in FACS tubes and before surface 
staining, 1 µL of CD16/32 antibody was added to the cells and they were incu-
bated for 10 min on ice, to block unspecific antibody binding to surface FcγRs. 
After washing with PBS/ 1% FCS and centrifugation at 1.500 rpm and 4°C for 
5min, supernatant was removed and relevant fluorochrome-conjugated antibod-
ies were added in appropriate dilutions to 100 µL cell suspension and were incu-
bated for 15 min at 4°C in exclusion of light. Next, cells were washed with PBS to 
remove remaining FCS, centrifuged at 1.500 rpm and 4°C for 5min, supernatant 
was removed and cells were resuspended in 1 mL PBS/ 2% formaldehyde and 
incubated for 15 min at 4°C for fixation of the cells and to avoid contamination of 
the machine. After a last washing step with PBS/ 1% FCS, cells were analysed 
via flow cytometry. For intracellular staining, cells were resuspended in and 
washed with saponin buffer in order to permeabilise cell membranes and cells 
were centrifuged again at 1.500 rpm and 4°C for 5 min. Hereafter, fluorochrome-
conjugated antibodies were added in appropriate dilutions to 100 µL of cell sus-
pension and were incubated for 15 min at 4°C under exclusion of light. Subse-
quently, cells were washed with saponin buffer and PBS/ 1% FCS and analysed 
by flow cytometry. 
 
3.6.6.  Colon ex vivo culture 
 
To measure the cytokine and antibody profile of physiologically intact colonic sec-
tions ex vivo, a 1 cm distal piece of colon was incubated with 1 mL RPMI complete 
medium supplemented with non-essential amino acids. After 24 h of incubation 
at 37°C and 5% CO2, the supernatant was collected and stored at -20°C until 
use for ELISA.  
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3.6.7.  Collection of serum 
 
In order to measure antibody concentration in the serum, complete blood was 
obtained from the murine heart and the blood plasma was separated from blood 
cells. For this purpose, an elsewhere described method was used [Ferreira et al., 
2011]. In short, collected blood was incubated for 30 min at RT to enable agglu-
tination of blood cells. Next, blood was incubated for 10 min at 4°C, followed by 
centrifugation at 400 g and 4°C for 10 min. The serum-supernatant was collected 
and stored at -20°C until use for ELISA. 
3.6.8.  Collection of colonic lumen 
 
To enable differentiation between the antibody- and cytokine-profile of the colonic 
tissue and lumen, the luminal content was collected using a published method 
[Ferreira et al., 2011]. In brief, the colon was flushed with 2 mL PBS/ 2% nonfat 
dry milk using a 10 mL syringe. Contend was homogenised and centrifuged at 
1.500 x g and 4°C for 5 min. Supernatant was collected, supplemented with pro-
tease inhibitor cocktail (1 µL/ mL) and stored at -80° until being used for ELISA.  
 
3.6.9.  Gentamycin protection assay 
 
To test the pathogen-uptake-efficiency, a gentamycin protection assay was im-
plemented [Mohamad et al., 2010]. 1x106 neutrophils were centrifuged in a FACS 
tube together with 1x107 C. rodentium, in a total volume of 200 µL at 1.300 rpm 
and 37°C for 5 min to bring neutrophils in close contact. Cells were then incubated 
for 60 min at 37°C and 5% CO2. After incubation, 500 µL gentamicin (100 µg/ 
mL) was added and cells were incubated for another 30 min at 37°C and 5% CO2 
to kill extracellular bacteria. Hereafter, cells were washed three times with PBS/ 
1% FCS and centrifuged at 1.300 rpm and 37°C for 5 min, to remove residual 
gentamicin. Next, neutrophils were lysed using 100 µL PBS/ 1% Triton X and 
incubated for 10 min on ice. In order to lyse all cells completely and release en-
gulfed bacteria, cell mixture was vortexed thoroughly. Finally, dilution series were 
performed as described before (3.2.3). 
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3.7. Biochemical methods 
 
3.7.1.  ELISA (cytokines) 
 
ELISA is a photometric assay, used to detect and quantify substances like cyto-
kines, in accordance with standard-reference-values. To quantify IL-17 in colon 
culture ex vivo, ELISA was performed according to manufacturer´s instructions 
for mouse IL-17 Duo Set ELISA kit. MAXI SORP 96-well plates were coated with 
50 µL capture antibody (2 ng/ mL) and incubated ON at 4°C. Wells were washed 
twice with washing buffer, followed by incubation for 2 h at RT with 200 µL block-
ing buffer to avoid unspecific binding. After washing twice with washing buffer, 40 
µL of sample was transferred to two wells. Also, standard serial dilution was per-
formed, starting with 1 ng/ mL till 15 pg/ mL of respective standard protein and 
transferred to wells in duplicates. 6 wells were filled with blocking buffer for con-
trols and plate was incubated at 4°C ON to allow binding of antigens to capture 
antibodies. Next, the plate was washed 4x with washing buffer and 50 µL of de-
tection antibody (400 ng/ mL) was added to each well except blank control. The 
plate was incubated for 1-2 h to allow binding of detection antibody to sample-
antigen. After 6 washing steps with washing buffer, 100 µL of streptavidin-alkaline 
phosphatase-conjugated antibody (1:10.000 in blocking buffer) was added to 
each well except blank control and incubated for 12-15 min to allow binding of 
streptavidin to biotin-conjugated detection antibody. After 8 washing steps, 100 
µL of para-nitrophenylphosphate (1 mg/ mL in di-ethanol-amine buffer) was 
added, which is a chromogenic substance that gets hydrolysed by alkaline phos-
phatase into yellow para-nitrophenol, detectable with a visible light spectropho-
tometer at 405nm. Wavelength correction was performed subtracting the absorb-
ance at 490 from the absorbance at 405nm and standard values were used for 
quantification. 
 
3.7.2.  ELISA (C. rodentium-specific IgG) 
 
For detection of C. rodentium-specific-IgG from colon [Ferreira et al., 2011], wells 
were coated with C. rodentium-lysate. In order to obtain C. rodentium-lysate, 
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ON-culture of C. rodentium was centrifuged at 4000 rpm and 4°C for 10 min. 
Pellet was washed 3x with PBS and bacterial suspension was transferred to a 
glass test tube under sterile conditions and was sonicated for 30 min at 4°C at 
full power. Total-lysate was further centrifuged twice at 4000 rpm and 4°C for 10 
min and supernatant was collected. Protein concentration from lysate was quan-
tified via Pierce protein assay. This is a colorimetric method for the detection and 
quantification of total protein. In short, a bicinchoninic acid (BCA) working reagent 
is added to the sample and to a diluted albumin (BSA) standard. This method 
involves two important reactions. First the protein peptide bonds reduce Cu2+ ions 
to Cu+ and this Cu+ then chelates with bicinchonic acid and forms a coloured 
complex, measurable with a visible light spectrophotometer at 550 nm. Therefore, 
the Cu+ and coloured complex concentration equals the protein concentration 
and can be quantified using the diluted standard as reference values. For ELISA, 
MAXI SORP 96-well plate was coated with 50 µL (10 µg/ mL) C. rodentium-lysate 
and incubated ON at 4°C. Next, wells were washed twice with washing buffer and 
blocked with 200 µL blocking buffer for 2 h at RT. After 2 washing steps, 50 µL 
sample (serum, colon culture or colonic lumen) or 50 µL blocking buffer for con-
trols wasa added in duplicates and the plate was incubated ON at 4°C, to allow 
binding of mouse antibodies from sample to bacterial lysate. After 5 washing 
steps, 100 µL of horseradish peroxidase-conjugated antibody (1:4000) was 
added to all wells except blank control and the plate was incubated for 1 h at RT 
to allow binding of detection antibody to the IgG-C. rodentium-complex. After an-
other 7 washing steps with washing buffer, 50 µL of AB substrate, containing 
luminol was added to each well and incubated for 30 min at RT in the dark, to 
allow the horseradish peroxidase the oxidation of luminol to 3-aminophthalate, a 
reaction accompanied by emission of light at 450nm, detectable with a visible 
light spectrophotometer. Wavelength correction was performed subtracting the 
absorbance at 570 from the absorbance at 450nm. 
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3.8. Molecular biology methods 
 
3.8.1.  Total RNA extraction from colon (Tri Reagent) 
 
For total RNA extraction Tri Reagent was used, a mixture of guanidine thioacya-
nate and phenol, that separates DNA and protein from RNA, after homogenisa-
tion of tissue sample. 1 mL of Tri Reagent was added to 2 mL reaction tubes, 
containing 50-100 mg of colon tissue samples and homogenised on ice using a 
homogeniser. Tubes were centrifuged at 12.000 x g and 4°C for 10 min to sepa-
rate RNA from cell debris and the clear supernatant was collected in a new 2 mL 
reaction tube and incubated for 10 min at RT to allow dissociation of nucleopro-
tein-complexes. Next, 200 µL of chloroform was added and samples were vor-
texed for 15 min, incubated for 10 min at RT and centrifuged at 2.000 x g and 4°C 
for 5 min to separate proteins from DNA and RNA. The RNA-containing upper 
aqueous phase was collected and transferred to a new 1,5 mL microcentrifuge 
tube and 500 µL of 2-propanol was added, mixed gentile and incubated for 10 
min at RT. After centrifugation at 12.000 x g and 4°C for 10 min, the supernatant 
was discarded and the RNA-pellet was frozen at -20°C ON to improve purity. 
After centrifugation at 7.500 x g and 4°C for 5 min, to remove residual salts, RNA-
pellet was air-dried for 10 min at RT, resuspended in 30 µL nuclease-free and 
deionised water and incubated for 15-20 min at 60°C. Total RNA concentration 
was determined using a NanoDrop and samples were stored at -80°C until use. 
 
3.8.2.  Total RNA extraction from neutrophils 
 
Activated neutrophils contain highly concentrated RNases, therefore Tri Reagent 
cannot be used for RNA isolation and RNA-stabilising RNAprotect Cell Reagent 
is required. For RNA extraction 1x106 neutrophils were centrifuged at 1.700 rpm 
and 4°C for 5 min, 300 µL RNAprotect Cell Reagent was added and sample was 
vortexed thoroughly. Hereafter, sample was centrifuged at 5.000 x g and RT for 
5min, supernatant was removed, pellet resuspended by snapping and 350 µL 
buffer RLT Plus was added. Next, the sample was vortexed and homogenised on 
ice using a homogeniser to release RNA from cells. The homogenised lysate was 
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then transferred onto a gDNA Eliminator spin column and centrifuged at 8.000 x 
g and RT for 30sec to eliminate contaminating gDNA by binding to the column. 
RNA-containing flow-through was supplemented with 350 µL of 70% ethanol, 
mixed, loaded onto a RNeasy spin column and centrifuged at 8.000 x g and RT 
for 15 secs to allow binding of RNA to column. Next, 700 µL of buffer RW1 was 
loaded on column which was centrifuged at 8.000 x g and RT for 15 sec. This 
was followed by 2 washing steps, in which 500 µL buffer RPE was loaded on the 
column and centrifuged at 8.000 x g and RT for 15 sec. To eliminate all liquid, 
column was centrifuged at full speed for 1 min at RT. Finally, the column was 
placed in a new 1,5 mL microcentrifuge tube, loaded with 30 µL nuclease-free 
and deionised water and centrifuged at 8.000 x g and RT for 1 min. The eluted 
RNA-water was re-loaded on the column and again centrifuged at 8.000 x g and 
RT for 1 min to increase RNA-yield. Total RNA concentration was determined 
using a NanoDrop and samples were stored at -80°C until use. 
 
3.8.3.  cDNA synthesis for qRT-PCR 
 
In order to transcribe extracted RNA into DNA, cDNA synthesis method was 
used. According to the manufacturer´s instructions, 500 ng RNA was mixed with 
specific amounts of reverse transcriptase, reaction buffer, RNase inhibitor, oligo-
dT primers, nucleotide triphosphates (dNTPs) and nuclease-free water in a 200 
µL microcentrifuge tube. PCR cycler was used with distinct cycle of 42°C for 1 h, 
70°C for 5 min and 8°C for hold step. Sample without addition of reverse tran-
scriptase was used as control for gDNA contamination. The cDNA was stored at 
-20C° until use for qRT-PCR. 
 
3.8.4.  qRT-PCR 
 
For mRNA detection, qRT-PCR was performed on a qPCR device. In principle, 
during DNA replication SYBR Green intercalates between base pairs and is de-
tected by device. The more primer-specific DNA is present in the beginning, the 
more DNA product can be replicated, the more SYBR Green can intercalate and 
can be detected by device. Primer for approved housekeeping genes serve as 
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references. For each experiment a freshly prepared SYBR Green master mix was 
prepared containing 30,25 µL nuclease-free water, 5 µL 10x reaction buffer, 3,5 
µL MgCl2, 2 µL dNTPs, 1,25 µL appropriately diluted specific forward and reverse 
primers, 1,5 µL SYBR Green and 0,25 µL Hot Gold Star DNA polymerase. 18 µL 
of the master mix was transferred to two wells of a qRT-PCR plate and 2 µL of 
appropriately diluted cDNA was added to each well. The plate was centrifuged at 
1.500 rpm at RT for 5 min and following program was used for amplification: 95°C 
for 10 min, 40 x (95°C for 15 sec; 60°C for 60 sec). Specificity of the amplicons 
was confirmed by evaluating amplicon of control for gDNA contamination and 
melting curve of the products. Primer pairs used for analysis are listed in section 
2.8.. Gene expression was quantified by normalisation to expression of house-
keeping genes Hprt-1 and expression in control cells using the ΔΔCt method. 
 
3.9. Statistics 
 
Data are present as mean ± SEM and were analysed with GraphPad Prism 
(GraphPad Software). Significance was tested by Student t-test. 
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4. Results 
 
4.1. Asymptomatic infections in GF mice 
 
We and other groups could show that GF mice are not able to clear infections 
with C. rodentium, instead they carry the pathogen lifelong and may infect other 
animals [Kamada et al., 2012. This situation resembles asymptomatic EPEC car-
riers, which unknowingly spread bacteria and thus may infect people, without be-
ing aware of their risk to spread pathogens. It is believed that such carriers make 
up the major EPEC reservoir [Nataro and Kaper, 1998].  
 
To examine if C. rodentium infection proceeds also asymptomatically in GF mice, 
murine colons were taken for analysis before and after infection with C. rodentium 
(days 0, 8 and 50). Due to their ability to induce systemic inflammation, IL-17A, 
TNF-α and IFN-γ [Xu and Cao, 2010; Zhang and An, 2007; Sano et al., 1999], 
were chosen as key markers for tissue pathology. mRNA expression was deter-
mined via qRT-PCR. In parallel, histological scores and faecal bacterial counts 
were quantified.  
As expected, prior to infection no IL-17A, TNF-α and IFN-γ mRNA expression 
was detected in colon of GF mice (Fig. 1A). However, 8 days p.i. with C. ro-
dentium, a 15-, 20- and 40-fold upregulation of IL-17A, TNF-α and IFN-γ mRNA 
expression was observed, respectively, as compared to d 0. These immune re-
sponses declined drastically on d 50 p.i., reaching mRNA expression level before 
infection.  
The same observation holds true for HE stained colonic sections. On d 8 p.i., 
strongly increased epithelial hyperplasia with elongation of crypts and loss of gob-
let cells, along with infiltration of inflammatory cells was detected (Fig. 1B). In 
contrast, on d 50 p.i., epithelial cell layers were well-organised and crypts were 
of normal lengths, similar to those prior to infection. CFU determination in faecal 
samples revealed high bacterial load, not only during inflammation on d 8, but 
also on d 50 where tissue pathology decreased (Fig. 1C).  
 
These data clearly show that the pathogen induces inflammatory immune re-
sponses in the beginning of infection (d 8 p.i.) and thereby promotes intestinal 
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tissue damage. This changes at later time points (d 50 p.i.), when despite high 
bacterial load, inflammatory responses fully decline and reach a pre-infection-
status. Hence, it can be postulated that infection of GF mice with C. rodentium 
can be used as a model of asymptomatic EPEC-carriers. 
 
 
 
Figure 1. Cytokine expression and histological analysis of GF mice infected with C. ro-
dentium. GF mice were infected with C. rodentium and (A) il-17a, tnf-α and ifn-γ mRNA levels 
were determined in the colon by qRT-PCR. Data represent mRNA expression relative to that in 
uninfected GF mice, n = 3 mice. (B) Colon sections of GF mice stained with HE for histology. 
Data represent one of two independent experiments, n = 5 mice. (C) Pathogen load was deter-
mined in the faeces, n = 3 mice. For (A) and (C) Results are means ± SEM and representative of 
two experiments.  
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4.2. Decreased neutrophil influx in absence of commensal bacteria 
 
FcγRs, along with IgGs are important factors for phagocytosis and were also 
shown to be involved in sterile elimination of C. rodentium [Maaser et al., 2004; 
Masuda et al., 2008]. Professional phagocytic cells, such as neutrophils [Kamada 
et al., 2015] and macrophages, [Kim et al., 2011] participate in the immune de-
fence against enteric pathogens. We were wondering, if in the absence of the 
intestinal microbiota these cells were missing or reduced, giving a possible ex-
planation for persistence of C. rodentium in GF mice. Interestingly, Kamada et al. 
reported equivalent neutrophil numbers in colon of GF and normofloric mice, 12 
d p.i. with C. rodentium. But since it is known that neutrophils act in very small 
time windows of 2-3 days [Lord et al., 2001], we decided to investigate in greater 
detail, when and to what extent phagocytes migrate into the colon of GF and 
specific pathogen free (SPF) mice in response to C. rodentium.  
In order to investigate this, GF and SPF mice were infected with overnight culture 
of C. rodentium and colonic CD11b+ Ly6C+ Ly6G+ neutrophils [Flemming et al., 
1993], as well as CD11b+ Ly6C+ Ly6G- and CD11b+ Ly6Chigh Ly6G- macrophages 
[Daley et al., 2007] were quantified on d 2, 4, 7, 8, 9, 10, 12, 14 and 16 p.i. by 
flow cytometry.          
In normofloric mice, no colonic neutrophils were detected at early time points of 
infection with C. rodentium (d 2-4 p.i.). From d 7 on the neutrophil numbers in-
creased constantly, reaching a peak on d 10, which comprised 140.000 cells and 
decreased afterwards (Fig. 2A). Similarly, in GF mice monocolonised with C. ro-
dentium, very low neutrophil numbers were found in the colon at early time points 
(d 2-4 p.i.). In these mice neutrophil counts slightly increased on d 7, peaked on 
d 8 p.i., reaching up to 40.000 cells and decreased afterwards. In these mice, a 
second even smaller peak was visible on d 14 p.i., which declined later. For ad-
equate interpretation, the neutrophil peaks in presence and absence of gut mi-
crobiota were compared. This comparison revealed that in absence of gut micro-
biota neutrophil frequencies and absolute cell numbers were 2-3-fold downregu-
lated as compared to normofloric mice. Contrary to neutrophils, C. rodentium in-
fection did not induce a noticeable CD11b+ Ly6C+ Ly6G- macrophage influx, nei-
ther in GF, nor in SPF mice (Fig. 2B). Direct comparison of macrophage peaks 
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(d 9 p.i. in SPF and d 8 p.i. in GF mice), revealed no significant differences, nei-
ther in macrophage frequency, nor in absolute cell number. The same observa-
tion holds true for CD11b+ Ly6Chigh Ly6G- macrophages (Fig. 2C). Upon infection, 
almost none of these cells were detectable in the colon of GF and SPF mice.  
Comparison of cell peaks (d 9 p.i. in SPF and d 12 p.i. in GF mice) revealed no 
significant difference, neither in macrophage frequency, nor in absolute cell num-
ber.  
In order to confirm data obtained by flow cytometry, regarding neutrophil migra-
tion and to visualise neutrophil influx into the colonic lumen, HE staining was per-
formed of colon sections obtained from SPF mice on d 10 p.i. and from GF mice 
on d 8 p.i..  
In SPF mice immunohistology of HE-stained colon sections revealed a massive 
influx of neutrophils into the colon and colonic lumen, 10 days p.i. (Fig. 2D). In 
GF mice, less neutrophils were visible in the colonic lumen.  
In summary, infection with C. rodentium induces a very strong influx of neutro-
phils, but not macrophages into the colonic tissue and lumen of normofloric mice. 
This neutrophil influx is strongly decreased in absence of gut microbiota, sug-
gesting a strong impact of commensal bacteria on neutrophil migration into the 
intestine and therefore on eradication of C. rodentium. 
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Figure 2. Neutrophil and macrophage counts in the colon of SPF and GF mice infected with 
C. rodentium. Normofloric and GF mice were infected with C. rodentium. Colonic cells were iso-
lated, stained for (A) CD11b+ Ly6C+ Ly6G+ neutrophils, (B) CD11b+ Ly6C+ Ly6G-macrophages 
and (C) CD11b+ Ly6Chigh Ly6G- macrophages and analysed by flow cytometry. Results represent 
mean ± SEM and are representative for three independent experiments, n = 3 mice. N.S.: Not 
significant, ***P<0,001, using unpaired t-test. (D) Colon sections of GF and SPF mice were 
stained for HE and used for histology. Data represent one of two independent experiments, n = 5 
mice.  
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4.3. Impact of neutrophils on clearance of C. rodentium 
 
Neutrophils are known to contribute to immune responses against C. rodentium 
[Spehlmann et al., 2009]. Previous experiments showed that neutrophil influx is 
decreased and pathogen burden elevated in absence of gut microbiota. We 
wanted to examine the direct impact of neutrophils on clearance of C. rodentium. 
Therefore, we wanted to test i) if there is a correlation between neutrophil influx 
and bacterial load and ii) if absence of neutrophils can affect clearance of the 
pathogen.  
To evaluate bacterial titres during infection course, SPF and GF mice were in-
fected with C. rodentium and bacterial titres were measured in stool samples on 
d 2, 4, 7, 8, 9, 10, 12, 14 and 16 p.i..  
During the course of infection, in SPF mice C. rodentium titre increased slowly 
and peaked on d 7 p.i., reaching 1x108 CFU/g (Fig. 3A). Afterwards, it decreased 
slightly and from d 10 on, it decreased very rapidly. In contrast, GF mice displayed 
a constant bacterial load of 1x109 CFU/g. Since bacterial load decreased and 
neutrophil influx peaked on d 10 p.i., a converse relation between pathogen load 
and neutrophil numbers was concluded. 
To examine, if absence of neutrophils affects pathogen clearance, SPF mice 
were infected with overnight culture of C. rodentium. Neutrophils were directly 
depleted by i.v. injection of antibodies on d 5, 8, 11, 14 and 16 p.i. and C. ro-
dentium titres were quantified in stool samples. For neutrophil depletion two dif-
ferent antibodies were used, clone RB6-8C5 which depletes neutrophils along 
with Ly6Chigh macrophages [Daley et al., 2007], and clone NIMP-R14 which is 
more specific for neutrophils [Charmoy et al., 2009].  
Infection of untreated control mice displayed the known picture, bacterial load 
peaked on d 8 p.i. reaching almost 1x1010 CFU/g, decreased afterwards and was 
not detectable on d 18 p.i.. In contrast to untreated controls, mice administered 
with clone RB6-8C5 failed to clear infection on d 18 p.i. (Fig. 3B). Instead, C. 
rodentium was still detectable in stool samples until d 30 p.i.. Mice treated with 
clone NIMP-R14 cleared infection almost simultaneously on day 32 p.i.. The Per-
sistence of C. rodentium in normofloric mice, exactly for the neutrophil-depletion-
period, clearly shows the impact of neutrophils on C. rodentium-clearance. 
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Taken together, these experiments demonstrate i) neutrophil influx correlates 
with a decrease of bacterial burden and ii) depletion of neutrophils leads to per-
sistence of C. rodentium during the depletion period. As soon as depletion termi-
nates, bacterial clearance starts again.  These data collectively show that neutro-
phil influx not only correlates with, but is indispensable for clearance of C. ro-
dentium.  
 
 
 
Figure 3. Faecal C. rodentium load in presence and absence of gut microbiota and neutro-
phils. (A) SPF and GF mice were infected with C. rodentium and bacterial load was quantified in 
faeces over the indicated time, n = 3 mice. (B) Normofloric WT mice were infected with C. ro-
dentium. One group was administered with RB6-8C5, another with NIMP-R14 antibodies on d 5, 
8, 11, 14 and 16 p.i., and the control group remained untreated, n = 3 mice for untreated WT 
group and n = 5 mice for RB6-8C5- and NIMP-R14-treated group. Bacterial load was quantified 
in faeces. Data points are mean ± SEM and results are representative for two independent ex-
periments. 
 
4.4. Gut microbiota affects neutrophil migration but not development  
 
Preliminary experiments showed that neutrophil counts peaked in the colon of GF 
mice on d 8 p.i. and of SPF mice on d 10 p.i. with C. rodentium. Direct comparison 
of these peaks revealed strongly reduced neutrophil counts in colon of GF mice, 
suggesting a strong impact of gut microbiota on neutrophil migration. However, 
not only the migration of neutrophils might be affected in these mice but also the 
development, leading to low neutrophil numbers in the intestine.  
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To address this suggestion, GF and SPF mice were infected C. rodentium and 
neutrophil counts were quantified in blood from GF (d 8 p.i.) and SPF mice (d 10 
p.i.) using flow cytometry. For this analysis, the time points of maximal neutrophil 
influx into colons were chosen, since we suppose neutrophil influx to represent 
the peak of immune response against C. rodentium. 
Upon infection with C. rodentium similar levels of neutrophils were measured in 
blood obtained from GF (d 8 p.i.) and SPF mice (d 10 p.i.), comprising approxi-
mately 200.000 neutrophils per mL blood (Fig. 4A). The presence of normal neu-
trophil counts in the blood of C. rodentium-monoclonised mice led us to the con-
clusion that gut microbiota does not influence the development of neutrophils in 
the bone marrow. Furthermore, we concluded that commensal bacteria do not 
influence neutrophil migration from bone marrow into the blood circulation, but 
only the migration into the intestine. 
To examine, if impaired colonic neutrophil influx in GF mice during C. rodentium-
infection might reflect a more general gut microbiota-mediated phenomenon, 
neutrophil counts were quantified during sterile peritonitis. For this purpose, GF 
and SPF mice were treated intraperitoneally with thioglycolate, a substance 
known to induce sterile inflammation. 4 h after treatment, neutrophils were quan-
tified in peritoneal lavages using flow cytometry.  
In normofloric mice, administration of thioglycolate induced a massive influx of 
inflammatory cells into the peritoneal cavity, of which 50% and therefore 
8.000.000 cells were neutrophils (Fig. 4B). Contrary to this, GF mice failed to 
induce appropriate neutrophil influx, since only 6% and therefore less than 
1.000.000 neutrophils could be detected in these mice, suggesting a general mi-
crobiota-dependent defect.  
These data collectively show that not neutrophil development, but neutrophil mi-
gration into the colon is diminished in absence of gut microbiota. This phenome-
non is not restricted to orally administered enteropathogens.  
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Figure 4. Neutrophil numbers in the blood and peritoneum. (A) SPF and GF mice were in-
fected with C. rodentium and CD11b+ Ly6C+ Ly6G+ neutrophils were quantified in the blood on d 
8 p.i. in GF and on d 10 p.i. in SPF mice using flow cytometry. Results represent mean ± SD and 
are representative for two independent experiments, n = 5 mice per group. N.S.: Not significant, 
using unpaired t-test. (B) SPF and GF mice were administered i.p. with 2% thioglycolate and 
F4/80- Ly6G+ neutrophils were quantified in the peritoneal lavage using flow cytometry, n = 1 
mouse.  
 
 
 
 
 
43 
 
4.5. Colonic IL-17 secretion enables neutrophil migration  
 
It is well documented that IL-17 is crucial for neutrophil migration from blood to 
sites of infection [Kawaguchi et al., 2004; Kolls and Linden, 2004] and for defence 
against C. rodentium [Ishigame et al., 2009]. We were wondering what will be the 
impact of IL-17 on neutrophil migration during C. rodentium infection.  
To assess the importance of IL-17 for infection course, GF and SPF mice were 
infected with C. rodentium. IL-17A mRNA expression was quantified in the colons 
on d 5, 6, 7, 8, 9 and 10 p.i. by qRT-PCR. 
In both mouse groups IL-17A mRNA expression raised during course of expres-
sion, suggesting its relevance for infection. In SPF mice, IL-17A mRNA expres-
sion raised continuously and peaked, together with former mentioned neutrophils 
on d 10 p.i. (Fig. 5A). Similarly, in GF mice IL-17A mRNA expression peaked, 
together with neutrophil influx on d 8 p.i. (Fig. 5B), suggesting an impact of IL-
17A on neutrophil migration.  
In order to evaluate the direct impact of IL-17 on neutrophil migration into the 
colon during infection with C. rodentium, normofloric WT and il-17a/f-/- mice were 
infected and 10 d p.i. neutrophils were quantified in the colon by flow cytometry.  
Absolute cell numbers and frequencies of neutrophils were reduced in il-17a/f-/-, 
as compared to WT mice (Fig. 5C). While in colon of WT mice, more than 40.000 
neutrophil were detected on d 10 p.i. with, only 10.000 neutrophils were meas-
ured in the colon of il-17a/f-/- mice. These reduced neutrophil counts clearly show 
a direct impact of IL-17 on neutrophil migration.  
Since we showed that neutrophils are required for clearance of C. rodentium and 
that neutrophil influx is impaired in il-17a/f-/- mice, we next wondered if C. ro-
dentium-clearance is affected in these mice. To investigate this, normofloric WT 
and il-17a/f-/- mice were infected with C. rodentium and bacterial titres were 
quantified in stool samples during infection course.  
Both mouse groups displayed comparable Bacterial titres. But while WT mice 
cleared infection by d 16 p.i., il-17a/f-/- mice displayed decrease bacterial num-
bers on d 14 p.i. and cleared infection 6 days delayed on d 22 p.i. (Fig. 5D). 
Although dispensable for clearance, absence of IL-17 delays eradication of C. 
rodentium, suggesting its involvement in defence against the enteropathogen. 
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Collectively these data strongly indicate a substantial role of IL-17 for neutrophil 
migration into the intestine during infections with C. rodentium, although it is dis-
pensable for bacterial clearance.  
 
 
Figure 5. IL-17 expression and its impact on C. rodentium load and neutrophil influx. (A) 
SPF and (B) GF mice were infected with C. rodentium, and il-17a mRNA level was determined in 
the colon by qRT-PCR. Data represent mRNA expression relative to that in mice 5 d p.i., n = 3 
mice. (C) Normofloric WT and il-17a/f-/- mice were infected with C. rodentium. Colonic cells were 
isolated on d 10 p.i. and CD11b+ Ly6C+ Ly6G+ neutrophils were quantified using flow cytometry, 
n = 4-5 mice. (D) Normofloric WT and il-17a/f-/- mice were infected with C. rodentium and patho-
gen load was determined in the faeces, n = 5-7 mice. Results are means ± SEM and representa-
tive of two experiments. ***P<0,0006, using unpaired t-test.  
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4.6. Macrophages eliminate C. rodentium in absence of IL-17 
 
We postulated that clearance of C. rodentium is mediated by neutrophils in 
normofloric mice. Moreover, we could show that in il-17a/f-/- mice, in which neu-
trophil migration is impaired (d 10 p.i.), C. rodentium infection is cleared with de-
layed kinetic. We reasoned that i) neutrophil migration might be delayed in these 
mice or ii) other phagocytes might migrate into the colon and thus induce bacterial 
clearance.  
In order to address this point, il-17a/f-/- mice were infected with C. rodentium and 
colonic CD11b+ Ly6C+ Ly6G+ neutrophils, as well as CD11b+ Ly6C+ Ly6G- mac-
rophages were quantified every other day, starting from d 8 till d 16 p.i. using flow 
cytometry. 
Unlike WT mice, il-17a/f-/- mice displayed no neutrophil peak on d 10 p.i. (Fig. 
6A). On d 12 p.i. a small neutrophil peak containing less than 20.000 cells ap-
peared and decreased afterwards. Interestingly, macrophage counts increased 
continuously reaching almost 80.000 cells on d 14 p.i. and decreased afterwards. 
Since the macrophage influx peaked on d 14 p.i. in il-17a/f-/- mice and inversely 
correlated with bacterial load in these mice, we concluded that in absence of IL-
17A/F not neutrophils but macrophages clear infections with C. rodentium. 
The observation that macrophages compensate for neutrophils in absence of IL-
17A/F prompted us, to examine the effect of macrophage-depletion in normofloric 
il-17a/f-/- mice using clodronate liposomes. These liposomes enable depletion of 
macrophages because they were phagocytised by and induce apoptosis in these 
cells [Muthupalani et al., 2012].  
For this purpose, il-17a/f-/- mice were infected with C. rodentium and adminis-
tered with clodronate liposomes (i.p) every other day, starting from d 8 till d 16 
p.i.. In parallel, bacterial titres were quantified in stool samples. 
In contrast to untreated controls, macrophage-depleted mice did not clear infec-
tion on d 20 p.i. (Fig. 6B). Although in treated mice, bacterial titres decreased till 
d 20 p.i., the pathogen load of 1x106 CFU/g remained unchanged until termination 
of the experiment on d 40 p.i.. This experiment showed that depletion of macro-
phages results in long-term persistence of C. rodentium in normofloric il-17a/f-/- 
mice.  
46 
 
These data show that macrophages compensate for absent neutrophils and 
thereby enable il-17a/f-/- mice to clear infections with C. rodentium. Even more 
important, they demonstrate the impact of phagocytes and not that competition 
for nutrients triggers bacterial clearance, since phagocyte-depletion induces long-
term persistence of C. rodentium in presence of commensal bacteria. 
 
 
Figure 6. Role of macrophages on C. rodentium in il-17a/f-/- mice. Normofloric il-17a/f-/- mice 
were infected with C. rodentium. (A) Colonic cells were isolated and CD11b+ Ly6G+ Ly6C+ neu-
trophils along CD11b+ Ly6G- Ly6C+ macrophages were quantified using flow cytometry, n = 3 
mice. Results are means ± SEM (B) Infected il-17a/f-/- mice, left untreated or treted i.p. with 
clodronate liposomes were monitored for faecal C. rodentium-load, n = 6-7 mice.  Results are 
means ± SEM and pooled from two experiments. 
 
4.7. Colonic IL-17A secretion is decreased in absence of gut micro-
biota 
 
IL-17A and IL-17F belong to the IL-17 cytokine family and their contribution in 
defence against C. rodentium was already demonstrated for both cytokines [Ish-
igame et al., 2009]. Interestingly, expression is widely distributed among many 
cells, including TH17, Treg, NK and mast cells [Adami et al., 2014], ILCs and 
macrophages [Song, et al., 2008]. Having shown that IL-17 and gut microbiota 
influences neutrophil influx, we assumed that the expression of IL-17 and the 
influx of neutrophils is directly connected with the presence of commensal bacte-
ria. Several publications mentioned such a connection [Ivanov et al., 2009]. How-
ever, with respect to C. rodentium-infection, the influence of the microbiota was 
thought to play no role, as a similar expression of IL-17A was detected in the 
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colon of GF and SPF mice, 12 d p.i. with C. rodentium [Kamada et al., 2012]. 
Therefore, we were interested to i) identify the IL-17 family member cytokine, 
dominantly expressed during infections with C. rodentium, ii) to determine the 
main source of this cytokine and iii) to compare cytokine expression levels in 
presence and absence of gut microbiota, particularly during the time of maximal 
neutrophil influx into the colon.  
To identify the main cytokine and cell type after infection of normofloric mice with 
C. rodentium (d 10 p.i.), total immune cells were isolated from the colon and res-
timulated with phorbol 12-myristate 13-acetate (PMA) and Ionomycin for 24h. 
This restimulation enabled measurement of cytokines by mimicking T cell activa-
tion through TCR signalling and CD28 co-stimulation. Colonic IL-17A+, IL-17F+, 
along with CD4+ cells, CD8+ cytotoxic T cells, CD34+ mast cells, Ly6G+ neutro-
phils, F480+ macrophages and CD335+ NK cells were quantified using flow cy-
tometry.  
In our experimental setup about 0,5% of all cells expressed IL-17A, whereas IL-
17F expression was marginal, thus putting only IL-17A in the focus of further in-
vestigations (Fig. 7A). Moreover, only CD4+ cells were found to express IL-17A 
(Fig. 7A).  
In order to compare IL-17A expression levels in presence and absence of com-
mensal bacteria, SPF and GF mice were infected with C. rodentium. Total im-
mune cells were isolated from colon of SPF mice on d 10 p.i. and of GF mice on 
d 8 p.i. and cells were restimulated with PMA and Ionomycin for 24h. IL-17A+ 
cells were quantified using flow cytometry. In parallel, colon sections were used 
to quantify il-17a mRNA expression using qRT-PCR method and IL-17 protein 
concentration was determined in colon culture using ELISA.  
Flow cytometric analysis revealed comparable IL-17A frequencies in the colon of 
GF mice on d 8 and SPF mice on d 10 p.i.. Importantly, 3-fold more IL-17A+ cells 
were detected in the colon of SPF, compared to GF mice (Fig. 7B). Accordingly, 
colonic il-17a mRNA expression (Fig. 7C) and IL-17 protein expression (Fig. 7D) 
were 3-fold upregulated in colons of SPF as compared to GF animals. This indi-
cates an influence of the gut microbiota on IL-17A expression. 
In summary, these data show that i) cytokine IL-17A is expressed dominantly 
during C. rodentium infection, ii) CD4+ cells are the main source of IL-17A and iii) 
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reduced IL-17A levels are detectable in absence of gut microbiota. Therefore, it 
can be concluded that CD4+ cell derived IL-17A expression is reduced in absence 
of gut microbiota, leading to insufficient neutrophil influx and thus persistence of 
C. rodentium. 
 
A 
 
 
 
 
 
 
 
 
Figure 7. IL-17 expression in presence and absence of gut microbiota during infections 
with C. rodentium. (A) SPF mice were infected with C. rodentium, Colonic cells were isolated 
on d 10 p.i. and IL-17A+, IL-17F+, along with CD4+ cells, CD8+ cytotoxic T cells, CD34+ mast cells, 
Ly6G+ neutrophils, F480+ macrophages and CD335+ NK cells were quantified using flow cytom-
etry. Results are representative for two independent experiments, n = 3 mice. SPF and GF mice 
were infected with C. rodentium and (B) il-17a mRNA levels were determined in the colons by 
qRT-PCR in GF (d 8 p.i.) and SPF mice (d 10 p.i.). Data represent mRNA expression relative to 
that in GF mice, n = 6 mice. (C) Colonic cells were isolated from GF (d 8 p.i.) and SPF (d 10 p.i.) 
mice and CD4+ IL-17A+ cells were quantified using flow cytometry, n = 5-6 mice. (D) IL-17 ex-
pression was quantified in colon cultures using ELISA, n = 3-5 mice. For (B), (C) and (D) results 
are means ± SEM and representative of two experiments ***P<0,0008, using unpaired t-test. 
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4.8. Colonic CXCL2 secretion is decreased in absence of IL-17A 
and gut microbiota  
 
It is well documented that IL-17A does not directly recruit neutrophils, but rather 
enhances the expression of neutrophilic chemokines, such as CXCL1 and 
CXCL2 [Onishi and Gaffen, 2010]. These chemokines in turn attract neutrophils 
to sites of infection [Quinton et al., 2004]. Especially CXCL2 was shown to induce 
neutrophil migration in response to infection with C. rodentium [Spehlmann et al., 
2009]. For this reason, we were interested, if CXCL1 and CXCL2 expression cor-
relates with neutrophil influx and whether the chemokine expression is downreg-
ulated in absence of gut microbiota or in absence of IL-17A. 
In order to test if CXCL2 and CXCL1 expression correlate with neutrophil influx, 
SPF and GF mice were infected with C. rodentium. Colonic chemokine mRNA 
expression was quantified every day, starting from d 5 till d 10 p.i. using qRT-
PCR method.  
In SPF mice, the expression of cxcl2 mRNA continuously increased with time of 
infection and peaked on d 10 p.i. (Fig. 8A). In contrast, in GF mice cxcl2 mRNA 
expression peaked on d 8 p.i. and decreased afterwards (Fig. 8B). Surprisingly, 
cxcl1 expression was barely detectable in both, SPF (Fig. 8C) and GF mice (Fig. 
8D). Since cxcl2 expression increased upon infection and correlated with neutro-
phil influx in GF and SPF mice, we concluded that CXCL2 but not CXCL1 is im-
portant for neutrophil recruitment during infections with C. rodentium. 
To further examine the impact of gut microbiota on CXCL2 expression, GF and 
SPF mice were infected with C. rodentium and colonic cxcl2 mRNA expression 
was quantified on d. 10 p.i. in SPF and on d 8 p.i. in GF mice using qRT-PCR 
method. 
Direct comparison of colonic cxcl2 expression in GF and SPF mice during the 
peak of neutrophil influx revealed 2-fold lower chemokine expression in the colon 
of GF mice, clearly demonstrating an impact of gut microbiota on CXCL2 expres-
sion. 
To further test, if IL-17A influences CXCL2 expression, normofloric WT and il-
17a/f-/- mice (IL-17F was shown not to be expressed during infection and thus 
can be neglected) were infected with C. rodentium and cxcl2 mRNA expression 
was quantified in colon on d 10 p.i..  
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In relation to WT mice, significant less cxcl2 expression was detected in the colon 
of 17a/f-/- mice on d 10 p.i. with C. rodentium (Fig. 8F), showing that IL-17A en-
hances the expression of CXCL2. 
In summary, we observed that i) CXCL2 expression correlated with neutrophil 
influx during C. rodentium infection, ii) CXCL2 expression was downregulated in 
absence of gut microbiota and iii) IL-17A expression upregulated colonic CXCL2 
expression. These data indicate that in presence of gut microbiota C. rodentium 
infection induces a strong colonic IL-17A response, leading to a strong expres-
sion of CXCL2 and thus to a strong influx of neutrophils to sites of infection. 
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Figure 8. Influence of IL-17A/F and absence of the microbiota on CXCL2 and CXCL1 ex-
pression during infection with C. rodentium. SPF and GF mice were infected with C. ro-
dentium and cxcl2 mRNA levels were determined in the colon of (A) SPF and (B) GF mice by 
qRT-PCR. Colonic cxcl1 mRNA levels of (C) SPF and (D) GF mice measured by qRT-PCR. Data 
represent mRNA expression relative to that in mice on d 5 p.i., n = 3 mice. (E) Colonic cxcl2 
mRNA of SPF and GF mice measured by qRT-PCR. Data represent mRNA expression relative 
to that in GF mice, n = 5 mice. (F) WT and il-17a/f-/- mice were infected with C. rodentium and 
cxcl2 mRNA was determined in the colon on d 10 p.i. by qRT-PCR. Data represent mRNA ex-
pression relative to that in il-17a/f-/- mice, n = 7-9 mice. Results are means ± SEM and repre-
sentative of two experiments. *P<0,03, **P<0,007, using unpaired t-test. 
 
4.9. Attraction of neutrophils by the gut microbiota induces clear-
ance of C. rodentium  
 
Recently it has been reported that faecal microbiota transplantation to C. ro-
dentium-monocolonised mice induces pathogen clearance, due to bacterial com-
petition for nutrients [Kamada et al., 2012]. Earlier, we showed that absence of 
gut microbiota results in impaired neutrophil influx leading to lifelong persistence 
of C. rodentium. Here we wanted to investigate, if a transfer of complete gut mi-
crobiota to C. rodentium-monocolonised mice restores neutrophil influx and thus 
induces sterile clearance of the pathogen.  
Faecal microbiota from SPF mice was orally transferred to GF mice on d 3 after 
infection with C. rodentium. Bacterial titres were measured in stool samples every 
other day, starting from d 2 till d 20 p.i..  
The bacterial titre of GF mice that have been associated with microbiota (GFM) 
decreased slightly from 1x1010 CFU/g to 1x109 CFU/g on d 6 p.i.. Similar to the 
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titre of SPF mice on d 10 p.i. it strongly decreased and declined below the detec-
tion threshold on d 20 p.i.. Since clearance started in both groups with the strong 
decrease of pathogen load on d 10 p.i., it is reasonable that clearance in GFM 
mice is also neutrophil-mediated.  
To evaluate if in GFM mice the strong decrease in bacterial load on d 10 p.i. was 
associated with an influx of neutrophils, we studied the kinetic of neutrophils in 
the colon of GFM mice, infected with C. rodentium and associated with faecal 
microbiota from SPF mice on d 3 p.i.. Additionally, neutrophil counts were quan-
tified in the colon of GF (d 8 p.i.) and SPF (d 10 p.i.) control mice using flow 
cytometry.  
In GFM mice, neutrophils peaked in the colon on d 10 p.i., with about 70.000 
neutrophils, which is comparable to the neutrophil numbers measured in SPF 
mice at the same time point. As expected, significantly lower neutrophil counts 
(20.000) were measured in the colon of GF mice on d 8 p.i., demonstrating that 
transfer of gut microbiota increases neutrophil numbers in the colon. 
With these experiments we could show that transfer of gut microbiota to C. ro-
dentium-monocolonised mice recovers neutrophil influx into the colon and thus 
mediates pathogen clearance.  
 
 
Figure 9. Impact of microbiota transplantation on C. rodentium and neutrophils. SPF and 
GF mice were infected with C. rodentium. One group of GF mice was associated on day 3 p.i. 
with normal gut microbiota. (A) Pathogen load was determined in the faeces, n = 5 mice. (B) 
Colonic cells were isolated and CD11b+ Ly6G+ Ly6C+ neutrophils were quantified by flow cytom-
etry, with n = 3-5 mice. Results represent mean ± SEM and are representative for two independent 
experiments. **P<0,003, using unpaired t-test. 
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4.10. Gut microbiota enhances colonic IL-17A and CXCL2 expres-
sion 
 
We could show that in absence of gut microbiota, IL-17A and CXCL2 expression 
is reduced and results in impaired neutrophil influx and persistence of C. ro-
dentium. Furthermore, we demonstrated that transfer of faecal microbiota to C. 
rodentium-monocolonised mice, enhances the influx of neutrophils which subse-
quently results in clearance of the pathogen. Next, we wondered if this enhanced 
neutrophil influx is a consequence of upregulated IL-17A and CXCL2 expression 
in gut microbiota associated mice.  
To investigate the impact of faecal microbiota transplantation on IL-17A and 
CXCL2 expression, C. rodentium infected GF mice were left untreated or associ-
ated with faecal microbiota. The expression of IL-17A and CXCL2 was quantified 
on d 8 p.i in GF and on d 10 p.i. in SPF and GFM mice in colon via qRT-PCR and 
in supernatants of colon cultures by ELISA. 
Despite high standard deviations, a 2- to 3-fold upregulation of il-17a expression 
was detected in the colon of SPF and GFM mice as compared to GF mice (Fig. 
10A). Similar results were obtained for the amount of IL-17 protein (Fig. 10B). 
We observed further, significantly higher cxcl2 expression in the colon of SPF 
and GFM mice, compared to GF mice (Fig. 10C). It is interesting to note that only 
normofloric and microbiota-associated mice revealed such high standard devia-
tion.  
In summary, these data clearly show the inducible impact of microbiota on the 
expression of IL-17A and CXCL2, demonstrating their potential therapeutic influ-
ence on infections with enteropathogens.    
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Figure 10. The influence of microbiota on colonic expression of IL-17A and CXCL2. C. ro-
dentium infected SPF and GF mice were left untreated or associated with microbiota on d 3 p.i.. 
In GF (d 8 p.i.), along with SPF and GFM (d 10 p.i.) mice (A) il-17a expression was quantified in 
the colon by qRT-PCR. mRNA expression is related to GF mice, n = 6-7 mice. (B) IL-17 was 
quantified in supernatants from colon cultures via ELISA, n = 5-6 mice. (C) cxcl2 expression was 
measured by qRT-PCR. Data represent mRNA expression relative to that in GF mice, n = 7-9 
mice. Results are means ± SEM and representative of two experiments with. *<P0,02, **<P0,008, 
***P<0,003, using unpaired t-test. 
 
4.11. Gut microbiota does not impair neutrophil CXCR2 expression  
 
As the intestinal microbiota influences IL-17A and CXCL2, we next wondered 
whether the receptor CXCR2 which binds murine chemokines CXCL1, CXCL2 
and CXCL5 [Pruenster et al., 2009] is also influenced by the intestinal bacteria. 
Since neutrophil maturation takes place in the bone marrow and gut microbiota 
influences bone marrow cells [Clark et al., 2010], it was reasonable to investigate 
the impact of commensal bacteria on CXCR2 expression of bone marrow derived 
neutrophils.  
To test if CXCR2 expression is downregulated in absence of gut microbiota, SPF 
and GF mice were infected with C. rodentium. GF (d 8 p.i.) and SPF (d 10 p.i.) 
derived neutrophils were isolated from the bone marrow and enriched by positive 
selection via magnetic cell separation (MACS). Cxcr2 mRNA expression was 
measured in these cells via qRT-PCR and cell purity was quantified using flow 
cytometry.  
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Direct comparison of mRNA levels revealed slightly upregulated cxcr2 expression 
in GF as compared to SPF derived neutrophils (Fig. 11A). Neutrophil purity was 
about 95% in both groups, shown by Ly6G-FITC and Ly6G-PE double positive 
cells (Fig. 11B).   
This clearly demonstrates that commensal bacteria do not enhance the expres-
sion of CXCR2 in bone marrow neutrophils during infections with C. rodentium. 
Thus, CXCR2 expression is not a reason for impaired neutrophil influx in C. ro-
dentium-monocolonised mice.  
 
Figure 11. Influence of the microbiota on neutrophilic CXCR2 expression during C. ro-
dentium infection. SPF and GF mice were infected with C. rodentium. (A)  On d 10 p.i. in SPF 
and d 8 p.i. in GF mice neutrophils were isolated from bone marrow using MACS and cxcr2 ex-
pression was quantified by qRT-PCR. Data represent mRNA expression relative to that in GF 
mice, n = 5-6 mice. Results are means ± SD and representative of two experiments. *P<0,003, 
using unpaired t-test. (B) Purity of isolated Ly6G+-FITC Ly6G+-PE neutrophils was determined by 
flow cytometry. 
 
4.12. Gut microbiota influences ICAM-1 expression 
 
Adhesion molecule ICAM-1 is essentially involved in neutrophil migration [Radi 
et al., 2001] and defence against C. rodentium (in absence of PSGL-1 or P-se-
lectin) [Kum et al., 2010]. It has been shown that bacteria and bacterial compo-
nents [Huang et al., 1996], along with TNF-α and IFN-γ [Radi et al., 2001] en-
hance endothelial ICAM-1 expression. For these reasons, we next examined 
whether ICAM-1 expression is affected in GF mice during C. rodentium infection.  
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To investigate the impact of gut microbiota on colonic ICAM-1 expression, SPF 
and GF mice were infected with C. rodentium and faecal microbiota was trans-
ferred to GFM mice. ICAM-1 expression was visualised (ICAM-1 in green and 
Hoechst in blue) and quantified in colon sections on d 8 p.i. in GF and on d 10 
p.i. in SPF and GFM mice using Immunohistochemistry.  
Immunohistochemistry revealed that ICAM-1 was dominantly expressed between 
the cells in the middle of the colonic crypts (Fig. 12A), indicating expression by 
the endothelium. Interestingly, ICAM-1 expression was 3-fold downregulated in 
colon of GF mice on d 8 p.i. as compared to SPF and GFM mice on d 10 p.i. (Fig. 
12A). This finding indicates a direct impact of commensal bacteria on colonic 
ICAM-1 expression during infection.  
To test if IL-17A influences colonic ICAM-1 expression during infection with C. 
rodentium, infected WT and il-17a/f-/- mice were analysed for expression of 
ICAM-1 in the colon on d 10 p.i (ICAM-1 in green and Hoechst in blue) using 
Immunohistochemistry. 
This analysis revealed a 3-fold downregulation of ICAM-1 expression in the colon 
of il-17a/f-/- mice as compared to WT mice (Fig. 12B). For this reason, we pro-
pose a direct impact of IL-17A on colonic ICAM-1 expression during infection with 
C. rodentium.  
To further study if decreased ICAM-1 expression in the absence of gut microbiota 
correlates with decreased TNF-α and IFN-γ expression, infected SPF, GFM and 
GF mice were analysed for colonic TNF-α and IFN-γ expression via qRT-PCR 
method. 
As depicted in Fig. 12C and Fig. 12D, mRNA expression of both ifn-γ and tnf-α 
was 3-fold downregulated in the colon of GF mice, as compared to SPF and GFM 
mice. This correlation between reduced ICAM-1 and TNF-α as well as IFN-γ ex-
pression, suggests that ICAM-1 expression is influenced by these cytokines.  
 
In conclusion, these data clearly demonstrate that the microbiota upregulates co-
lonic ICAM-1 expression in an IL-17A- and probably also in a TNF-α- and IFN-γ-
dependant manner. Thus ICAM-1 expression might be involved in the impaired 
neutrophil influx in GF mice during infection with C. rodentium.  
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Figure 12. The influence of gut microbiota and IL-17A/F on ICAM-1 expression. (A) SPF and 
GF mice were infected with C. rodentium and left untreated or associated with microbiota on d 3 
p.i.. ICAM-1 (green) and Hoechst (blue) expression was quantified in colon section of GF (d 8 p.i.) 
and of SPF and GFF mice (d 10 p.i.) using ImageJ software, n = 5-6 mice. (B) Normofloric WT 
and il-17a/f-/- mice were infected with C. rodentium and ICAM-1(green) and Hoechst (blue) ex-
pression was quantified in colon sections on d 10 p.i. using immunohistochemistry, n = 6 mice.  
(C) ifn-γ and (D) tnf-α expression was quantified in the colon of SPF, GFM and GF mice by qRT-
PCR, with n = 6-7 mice. Results are means ± SEM. *<P0,02, **<P0,008, ***P<0,0008, using 
unpaired t-test. 
 
4.13. Involvement of the complement system in neutrophil migration 
 
The complement system is an important defence mechanism against invading 
pathogens. It is known to recruit neutrophils by anaphylatoxins, enhances phag-
ocytic uptake by opsoninsation and kills bacteria through MAC [Dunkelberger and 
Song, 2010]. Recently a role for defence against C. rodentium was assumed, 
since C3b was shown to enter the gut lumen and opsonise the pathogen, thereby 
enhancing phagocytosis [Balzer et al., 2011]. Therefore, we were interested, if 
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pathogen-clearance and neutrophil influx were impaired in complement-deficient 
mice. 
To investigate the role of the complement system on elimination of C. rodentium, 
normofloric WT, c3-/-, c5-/- and c5+/- mice were infected with C. rodentium and 
bacterial titre was measured in stool samples during course of infection. 
Contrary to WT mice, C3 deficient mice failed to clear C. rodentium infection after 
2-3 weeks p.i. (Fig. 13A).  Since the pathogen load was still detectable after 30-
60 d. p.i., clearance was strongly delayed in c3-/- mice, as compared to WT mice. 
In contrast, c5-/- mice cleared infection on d 18 p.i. and therefore showed similar 
antibacterial resistance as WT and c5+/- control mice (Fig. 13B). Remarkably, 
none of the complement deficient mice succumbed to infection. These results 
indicated that cleavage products of C3, such as anaphylatoxin C3a and opsonin 
C3b, are more important than C5 cleavage products, such as anaphylatoxin C5a 
and MAC-forming C5b. 
In order to investigate the impact of complement system on colonic neutrophil 
migration, WT and c3-/- mice were infected with C. rodentium and neutrophil 
numbers were quantified on d 10 p.i. in blood and colon using flow cytometry.  
In absence of C3, comparable neutrophil numbers were detected in blood of WT 
and c3-/- animals 10 d p.i. with C. rodentium, reaching absolute numbers of about 
250.000 cells (Fig. 13C). On the contrary, in the colon of c3-/- mice, neutrophil 
numbers were 4 times lower on d 10 p.i., as compared to control mice (Fig. 13D). 
These significantly reduced neutrophil counts in the colon, but not blood of c3-/- 
mice indicate the impact of C3 on neutrophil migration to sites of C. rodentium-
infection.  
These experiments revealed that C3 cleavage products but not C5 are crucial for 
clearance of C. rodentum, by recruiting neutrophils to the colon and probably by 
pathogen-opsonisation.  
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Figure 13. Impact of the Complement on bacterial clearance and neutrophil influx.  Mice 
were infected with C. rodentium and bacterial load was determined in the faeces at the indicated 
days p.i (A) normofloric WT and c3-/- mice, n = 3 (B) WT, C5+/- and C5-/- mice, n = 3-5. On d 10 
p.i., CD11b+ Ly6C+ Ly6G+ neutrophils were quantified in (C) blood and (D) colon using flow cy-
tometry, n = 4-5 mice per group. Results are means ± SEM and representative of two experi-
ments. N.S.: Not significant, **P<0,003, using unpaired t-test. 
 
4.14. Gut microbiota enhances colonic IgG expression  
 
B cell-derived IgG is crucial for clearance of C. rodentium, since IgG-deficient 
mice were not able to eliminate the pathogen [Maaser et al., 2004]. However, on 
d 12 p.i. with C. rodentium similar IgG levels were found in serum of GF and SPF 
mice [Kamada et al., 2012]. Based on our observations during neutrophil kinetics, 
we realised the importance of the right timing. For this reason, we examined C. 
rodentium-specific IgG secretion in greater detail.  
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To analyse C. rodentium-specific IgG levels in presence and absence of gut mi-
crobiota, SPF and GF mice were infected and C. rodentium-specific IgG was vis-
ualised in serum and colon culture every other day, starting d 5, till d 10 p.i., using 
ELISA.   
In serum of both, SPF and GF mice, the amount of Citrobacter-specific IgG in-
creased constantly during the course of infection and peaked simultaneously on 
d 10 p.i. (Fig. 14A). In contrast, IgG concentration in colon culture increased 
strongly in SPF but not in GF mice and peaked on d 10 p.i. in these mice (Fig. 
14B).  
To further investigate the impact of gut microbiota on IgG secretion in the colon 
of infected mice, C. rodentium-specific IgG was visualised in colon culture and 
colonic lumen during the time of maximal neutrophil influx on d 8 p.i. in GF and d 
10 p.i. in SPF and GFM mice using ELISA. These time points were chosen be-
cause opsonising IgG is only useful in the presence of phagocytes which we have 
shown to appear at these time points.  
In both, colon culture (Fig. 14C) and colonic lumen (Fig. 14D) SPF mice dis-
played significantly more Citrobacter-specific IgG, compared to GF mice. Alt-
hough not reaching the IgG levels measured in SPF mice, GFM mice displayed 
higher concentrations of IgG-antibodies, as compared to GF mice. These results 
show that gut microbiota influences C. rodentium-specific IgG secretion in the 
colon.  
Collectively, these data clearly show that commensal bacteria do not influence C. 
rodentium-specific IgG levels in serum, but they do so in the colon and colonic 
lumen. This leads to the idea that gut microbiota not only enhances neutrophil 
influx, but also colonic secretion of IgG-opsonins and therefore mediates efficient 
uptake and killing of pathogenic bacteria.  
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Figure 14. Influence of the microbiota on IgG secretion during infection with C. rodentium. 
SPF and GF mice were infected and C. rodentium specific IgG secretion was quantified at the 
indicated days p.i. in (A) serum and (B) colon cultures in GF, SPF and GFM mice using ELISA, n 
= 3 mice. C. rodentium infected SPF and GF mice were left untreated or associated with microbi-
ota on d 3 p.i..  C. rodentium-specific IgG levels were quantified by ELISA in (C) colon cultures 
and (D) the colonic lumen in GF, SPF and GFF mice, n = 5-6 mice per day. For (A-D) results are 
means ± SEM and representative of two experiments. ***P<0,0006, using unpaired t-test. 
 
4.15. Gut microbiota increases phagocytic activity of neutrophils 
 
Gut microbiota is known to stimulate phagocytic activity of neutrophils, as GF 
derived neutrophils have reduced phagocytic activity under steady state condi-
tions, as compared to SPF derived cells [Ohkubo et al., 1999]. For this reason, 
we examined, if infection with C. rodentium alone is sufficient to enhance the 
phagocytic activity, or if gut microbiota is required for activating properties. 
For this purpose, bone marrow neutrophils were isolated from infected GF (d 8 
p.i.), SPF (d 10 p.i.) and GFM mice (d 10 p.i.) using MACS. Gentamicin protection 
assay was performed to quantify phagocytised C. rodentium counts. In brief, iso-
lated neutrophils were infected with C. rodentium and extracellular bacteria were 
killed using gentamicin. In order to release the engulfed bacteria, cells were lysed 
with triton-X 100 and bacteria were plated on agar plates for colony counting. Cell 
purity was measured using flow cytometry. 
Neutrophils obtained from all three groups displayed phagocytosis of C. ro-
dentium (Fig. 15A). However, bone marrow neutrophils obtained from SPF and 
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GFM mice revealed significantly more engulfed bacteria, as compared to neutro-
phils from GF mice. In all groups, neutrophil purity was about 99%, shown by 
Ly6G-FITC and Ly6G-PE double positive cells (Fig. 15B). 
This clearly shows that despite the presence of pathogenic C. rodentium, gut mi-
crobiota further enhances the phagocytic activity of bone marrow neutrophils. 
This indicates that the presence of pathogens alone is insufficient to fully activate 
neutrophils and additional signals from commensal bacteria are required for an 
efficient uptake and elimination of pathogens.  
 
 
Figure 15. Phagocytic activity of GF and SPF neutrophils during infection with C. ro-
dentium. (A) SPF and GF mice were infected with C. rodentium and left untreated or associated 
with microbiota on d 3 p.i.. Neutrophils were isolated from the bone marrow of GF (d 8 p.i.)  and 
SPF and GFM mice (d 10 p.i.). Gentamicin protection assay was performed with isolated neutro-
phils and uptake of C. rodentium was quantified. Results are means ± SEM and representative of 
two experiments, with n = 21. *<P0,02, ***P<0,0002, using unpaired t-test. (B) Purity of isolated 
Ly6G+-FITC Ly6G+-PE neutrophils was determined by flow cytometry. 
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5. Discussion 
 
With this work, we could show that the immune response against C. rodentium is 
a very complex network of immune reactions, which are connected to phagocyte 
attraction, migration, pathogen uptake and killing. Interestingly, in many of these 
key-reactions, the gut microbiota is involved through amplification of certain im-
mune responses which are required for clearance of C. rodentium.  
 
5.1. Asymptomatic infections in GF mice 
A very interesting phenomenon is that upon EPEC infection, some adults can 
become asymptomatic carrier of the pathogen [Nataro and Kaper, 1998]. Alt-
hough they do not show any symptoms of disease, they continuously excrete 
infectious bacteria, unknowingly infecting other people and thereby spread the 
disease. The question comes up why some people become carrier of EPEC and 
some do not. We here suggest that the composition of gut microbiota determines 
whether or not someone becomes a carrier. The gut microbiota differs from per-
son to person and can therefore be seen as being as unique as a fingerprint 
[Schloissnig et al., 2012]. It is a complex ecosystem that comprises thousands of 
bacterial species and the composition of these diverse species plays a critical 
role for health and disease [Eckburg et al., 2005]. Under normal conditions, Clos-
tridium difficile for instance, is a commensal bacterium of the gut microbiota, but 
alterations in the bacterial ecosystem can cause a recurrent Clostridium difficile 
infection that can best be treated by microbiota transplantation, through the res-
toration of microbial balance [Gough et al., 2011]. Furthermore, malnutrition cor-
relates with EPEC infections in underdeveloped countries and diet is also known 
to influence the composition of the intestinal microbiome [Colon and Bird, 2014]. 
Therefore, it seems plausible that malnutrition disturbs the bacterial balance in 
the intestine of some people. Consequently, they lose important immune stimu-
lating intestinal bacteria and thus cannot eliminate an additional EPEC infection 
leading to them becoming EPEC-carriers. We were able to mimic this situation 
with C. rodentium infections in the absence of gut microbiota, in GF mice. Inter-
estingly, on d 8 p.i., C. rodentium induced an immune response in these mice, 
which declined afterwards and the mice became asymptomatic carriers of the 
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pathogen. Also, histological staining revealed that tissue damage was restricted 
to the beginning of the infection while at later time points, the tissue showed no 
signs of pathology. It has to be mentioned that the virulence genes of C. ro-
dentium were downregulated in both SPF and GF hosts at late time points of the 
infection [Kamada et al., 2012; Steinhoff et al., unpublished data]. This finding 
suggests that C. rodentium loses its pathogenicity island completely and there-
fore its infectivity. However, our group could demonstrate the infectivity of these 
long term persisting bacteria through co-housing experiments. Carrier mice were 
co-housed with SPF or GF mice, which resulted in upregulation of bacterial viru-
lence genes in the new hosts, followed by typical infection courses [Steinhoff et 
al., unpublished data]. This clearly shows that the bacterium does not lose its 
pathogenicity during long term persistence, instead it shows a reversible down-
regulation of the virulence genes, in parallel to immunological non-responsive-
ness. 
In summary, at late timepoints of infection, C. rodentium has inactive virulence 
genes and does neither cause pathological, nor immunological responses. On 
the other hand, the host provides nutrients and space for the bacterium. This is 
why C. rodentium benefits from the host without harming it what makes it a com-
mensal-like bacterium.  
 
5.2. Decreased neutrophil influx in absence of commensal bacteria  
 
All phagocytes, including neutrophils and macrophages, are important defence 
mechanisms against invading bacteria [Rabinovitch, 1995]. In case of C. ro-
dentium-infections, we observed massive migration of neutrophils into the colon 
upon infection. This finding agrees with previous studies showing that neutrophils 
migrate upon infection with C. rodentium into the colonic lamina propria, in a 
CXCR2 dependent manner and suggesting an involvement of neutrophils in host 
defence against C. rodentium [Spehlmann et al., 2009]. With respect to macro-
phages, we only found a slight increase in cell counts upon infection. Therefore, 
we assumed that macrophages are dispensable for clearance of this pathogen. 
However, macrophages were claimed to contribute to adaptive immune re-
sponses against C. rodentium by secreting IL-12, important for TH1 polarisation 
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and INF-γ, along with IL-17 expression [Schreiber et al., 2013]. In contrast, the 
increased neutrophil influx observed in colons of normofloric mice 10 d p.i. with 
C. rodentium together with the decreased influx in absence of gut microbiota sug-
gest an important role of microbiota-induced neutrophil migration for defence 
against C. rodentium. Several publications showed reduced neutrophil migration 
due to alterations in the gut microbiota. For example, in context of acute graft-
versus-host disease, it was shown that neutrophil infiltration was dependent on 
microbiota and was impaired in GF mice [Schwab et al., 2014]. Also, for infections 
with Listeria monocytogenes, a reduced influx of neutrophils into murine spleen 
has been demonstrated [Mittrücker et al., 2014]. Deshmukh et al., showed in 
2014 that antibiotic-treated and GF neonatal animals displayed reduced numbers 
of neutrophils and neutrophil progenitors in bone marrow and blood, in compari-
son to normofloric animals. Therefore, they concluded that both, the migration 
and the development of neutrophils are microbiota dependent. Additionally, Kan-
ther et al. reported 2014 that neutrophil numbers and migratory behaviour was 
decreased in germfree zebrafish. Contrary to these publications, Kamada et al., 
detected 2012 no altered neutrophil numbers in the colon of GF compared to 
normofloric mice, 12 d p.i.  with C. rodentium.  Our findings are in accordance 
with the data published by Kamada, regarding the chosen time point. 12 d p.i., 
we neither saw significant differences in neutrophil migration in absence or pres-
ence of gut microbiota. However, investigations of the complete neutrophil kinet-
ics in detail, revealed a neutrophil-influx-peak on d 10 p.i. in normofloric mice. 
This neutrophil peak was very short and neutrophil numbers decreased after-
wards very rapidly. Comparison of this peak with the peak that occurred in GF 
mice on d 8 p.i. showed significantly lower neutrophil numbers in absence of gut 
microbiota. This is in clear contrast to the findings of Kamada et al., whose finding 
are based on a single time point which was chosen too late. HE-staining showed 
that this neutrophil influx occurred not only in the colonic lamina propria, but also 
into the lumen of the colon which is in accordance with other publications 
[Kamada et al., 2015]. 
The identification and comparison of neutrophil-influx-peaks enabled us to extend 
published data, by showing that neutrophil influx is impaired in absence of gut 
microbiota during C. rodentium-infections. 
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5.3. Impact of neutrophils on clearance of C. rodentium 
 
It is already known that neutrophils play an important role during infection with C 
rodentium. 2007, Leibes et al. depleted neutrophils in normofloric WT mice, dur-
ing infection with C. rodentium and described an enhanced mortality rate, as well 
as elevated pathogen load in liver and spleen in depleted mice, compared to con-
trol mice. Additionally, Spehlmann et al. 2009 suggested a contribution of neutro-
phils to host defence against C. rodentium. This contribution was shown by the 
fact that CXCR2 deficient mice displayed disturbed neutrophil trafficking and de-
layed bacterial clearance. Also, neutrophil effector cell function was tested by ex 
vivo C. rodentium killing assay [Spehlmann et al., 2009]. Further, neutrophils 
were suggested to be involved in protection against infection associated diar-
rhoea. Thus, published data suggested a beneficial contribution of neutrophils to 
host defence, but none showed the direct impact of neutrophils on bacterial clear-
ance. Through investigation of bacterial titres and the influx of neutrophils, we 
could show a clear correlation between these two factors. As soon as the peak 
of neutrophils into the colon was reached, bacterial numbers decreased. We thus 
suggested that due to high bacterial numbers of 1x109 and a reproduction time 
of about 20 minutes, a certain threshold of neutrophil numbers is required to elim-
inate fast replicating C. rodentium. As soon as sufficient neutrophils have reached 
the site of infection and are able to shift the equilibrium between replication and 
elimination towards the latter one, less phagocytes are sufficient for final elimina-
tion. In order to study the impact of neutrophils on clearance, we used neutrophil-
depleting-antibodies, similar to Leibes et al.. The used antibody RB6-8C5 binds 
to Ly6G, present on neutrophils and to Ly6C expressed on neutrophils, DCs, 
some lymphocytes and monocytes, and therefore predominantly depletes neu-
trophils [Daley et al., 2007]. In contrast to that, the antibody NIMP-R14 is neutro-
phil specific and selectively depletes only neutrophils [Xia et al., 2005]. Depletion 
with both antibodies showed the same picture: bacterial clearance was delayed 
for 11 days, the period of depletion. The fact that both depleting antibodies have 
the same effect, underlines the importance of neutrophils for clearance, as de-
pletion of additional cells like monocytes had no further impact on clearance. This 
clearly indicates that neutrophils are cells enabling clearance of C. rodentium in 
normofloric mice.  
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The findings obtained from both experiments agree and extend other publications 
by showing a direct impact of neutrophils on C. rodentium-clearance.  
 
5.4. Gut microbiota affects neutrophil migration but not development  
 
In general, gut microbiota was shown to have a great influence on neutrophil mi-
gration [Amaral et al., 2008, Kanther et al., 2014], activity [Ohkubo et al., 1990] 
and development [Kugadas et al., 2016]. Balmer et al., 2014 even showed that 
reconstitution experiments with E. coli K-12, E. faecalis and S. xylosus were able 
to recover neutrophil maturation. By quantifying neutrophil counts in blood of GF 
and SPF mice p.i. with C. rodentium, we could show that the presence or absence 
of commensal bacteria does not affect neutrophil numbers in the blood. There-
fore, we concluded that gut microbiota neither affects neutrophil development, 
nor the migration from bone marrow into the blood circulation. We thus reasoned 
that the migration from the blood into the colonic lamina propria and into the co-
lonic lumen might be microbiota-dependent. Thioglycolate is used to induce ster-
ile peritonitis. Therefore, it was chosen as a method of pathogen-independent 
influx of neutrophils into the peritoneum of SPF and GF mice. In contrast to SPF 
mice, thioglycolate-treatment of GF animals did not lead to enhanced peritoneal 
neutrophil numbers after 4 h. This is comparable to the infection of GF mice with 
C. rodentium which resulted only in a mild increase as compared to normofloric 
mice. Since a sterile peritonitis shows similar migratory defects in GF mice, as 
compared to pathogen-induced inflammations, we suggest a general migratory 
defect of neutrophils in GF mice. This is in accordance with published data, which 
examined neutrophil recruitment upon various inflammatory stimuli, like zymo-
san, thioglycollate, and silicia, and found migratory defects in absence of com-
mensal bacteria [Karmarkar and Rock, 2013]. Further, neutrophil migration was 
shown to be restored by LPS treatment in a MyD88-dependant signalling path-
way [Karmarkar and Rock, 2013]. It would be interesting to administrate LPS i.v. 
to C. rodentium-monocolonised mice to see weather LPS driven TLR activation 
is sufficient to stimulate MyD88 pathways and therefore neutrophil migration.  
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Our findings demonstrate that GF mice have a general neutrophil migration de-
fect, which does not apply to the migration of cells from bone marrow to the blood, 
but rather from blood to inflammatory sites.  
 
5.5. Colonic IL-17 secretion enables neutrophil migration  
 
IL-17 is involved in neutrophil recruitment to sites of infection [Kawaguchi et al., 
2004, Kolls and Linden, 2004]. Recently it was published that both IL-17A and IL-
17F are involved in immune defence against C. rodentium, since il17a-/-, il17f-/- 
and il-17a/f-7-mice showed increased bacterial burden in the colon on day 14 p.i. 
with C. rodentium, as compared to WT mice [Ishigame et al., 2009]. In accord-
ance with previous studies, we observed increased bacterial burden in il-17a/f-/- 
mice on day 14 p.i. but even more importantly, bacterial clearance was slightly 
delayed for about 6 days, suggesting an involvement of IL-17A and IL-17F in 
immunity against this pathogen. Interesting is that IL-17A expression correlates 
with neutrophil influx and thus peaks on d 10 in SPF and on d 8 p.i. in GF mice, 
strongly suggesting a connection between IL-17A expression and neutrophil mi-
gration. Moreover, il-17a/f-/- mice harbour significantly lower neutrophil numbers 
in the colon, compared to WT mice, underlining the impact of IL-17 on neutrophil 
influx during infections with C. rodentium. It would be interesting to infect il-17a-
/- and il-17f-/- mice with C. rodentium to analyse and compare neutrophil numbers 
in the colon and thereby differentiate between effects of IL-17A and IL-17F re-
garding neutrophil migration in vivo. As mentioned before, neutrophils are part of 
the innate immune system and hence one of the first unspecific responders to 
infections [Rabinovitch, 1995]. In agreement with this, Lebeis et al. focused on 
early time points of infection with C. rodentium and published in 2007 that “TLR 
signalling mediated by MyD88 is required for a protective innate immune re-
sponse by neutrophils to Citrobacter rodentium”. This notion came from the find-
ing that neutrophil numbers were decreased on d 3 p.i. in the colon of myd88-/- 
mice as compared to WT mice. However, this difference in cell counts disap-
peared at the latest measured time point, d 7 p.i.. Together with our findings, 
which show a maximum neutrophil influx 10 d p.i., these data suggest a first non-
specific TLR mediated neutrophil influx on d 3 p.i. and a second, much stronger 
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influx on d 10, which finally correlates with pathogen clearance. This neutrophil 
influx might not be TLR dependent, but dependent on cells of the adaptive im-
mune response, such as T cells. This suggestion is supported by Mangan et al. 
who postulated 2006 that C. rodentium triggers a strong TH17 cell response.  
In summary, we show that IL-17 is involved in neutrophil recruitment to sites of 
C. rodentium-infection. 
 
5.6. Macrophages eliminate C. rodentium in absence of IL-17 
 
In the previous chapter, we showed that in normofloric mice a strong neutrophil-, 
but not macrophage-influx occurs which mediates clearance of C. rodentium-in-
fection. Further, our data revealed that also il-17a/f-/- mice are capable of patho-
gen clearance despite absence of colonic neutrophils. This could be explained 
by the fact that in the absence of neutrophils, macrophages migrate into the colon 
on d 14 p.i. and that this correlates with decreased bacterial numbers in il-17a/f-
/- mice. Accordingly, depletion of these infiltrating macrophages in il-17a/f-/- mice 
clearly demonstrated the importance of these cells for sterile clearance of C. ro-
dentium. However, it seems inexplicable that in il-17a/f-/- mice, absence of neu-
trophils led to the recruitment of macrophages to the infected colon, thereby in-
ducing pathogen clearance, whereas direct depletion of neutrophils in WT ani-
mals did not. One might speculate that the absence of IL-17A/F leads to a feed-
back to the immune system to compensate the lack of neutrophils by macrophage 
infiltration. If however, neutrophils are depleted in the presence of IL-17A/F the 
compensatory action of macrophages is not activated. It would be interesting to 
check at later time points of neutrophil depletion for macrophage migration into 
the colon. Another interesting finding is that macrophage influx in the absence of 
neutrophils does not occur if gut microbiota is missing because C. rodentium-
monocolonised mice display low macrophage counts, although neutrophils are 
missing in these mice. This suggests that in absence of commensal bacteria, not 
only neutrophil but also macrophage migration to the colon is affected. This find-
ing is in agreement with published data, which showed no differences in resident 
peritoneal macrophage cell counts in conventional and GF mice in steady state 
condition [Morland and Midtvedt, 1984], but upon stimulation with mineral oil, a 
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decreased peritoneal influx and C3b-receptor-mediated phagocytosis was shown 
in GF mice [Morland et al., 1979]. Furthermore, conventionalisation restored mac-
rophage functions in this experimental setup [Morland and Midtvedt, 1984]. Jungi 
and McGregor showed in 1978 that GF-derived macrophages are less activated 
in comparison to conventional mice derived cells because peptone induced mac-
rophages from GF mice responded poorly to chemotactic stimuli and monocyte 
recruitment was impaired in these mice.  
In summary, our experiments highlight that macrophages may compensate for 
absent neutrophils and are able to clear C. rodentium. Further, we suggest that 
gut microbiota influences the migration of both, neutrophils and macrophages into 
the colon. 
 
5.7. Colonic IL-17A secretion is decreased in absence of gut micro-
biota 
 
Different cells, including TH17 cells, Treg cells, NK cells, mast cells [Adami et al., 
2014], ILCs and macrophages [Song, et al., 2008] secrete IL-17 during C. ro-
dentium-infection. TH17 cells were shown to be the main source of IL-17 and 
both, IL-17A and IL-17F contribute to defence against C. rodentium [Ishigame et 
al., 2009]. Moreover, the finding that IL-17 is decreased in absence of gut micro-
biota is not new, since several publications addressed this topic already. For ex-
ample, Atarashi et al. published 2008 that the number of IL-17+ CD4+ T cells is 
strongly reduced in the intestine of GF mice compared to SPF mice in steady 
state situation. Upon infection with C. rodentium, Kamada et al. reported 2012 no 
significant difference regarding IL-17A expression in the colon of GF mice as 
compared to SPF mice. Although IL-17A and IL-17F were shown to be relevant 
for infections with the enteropathogen, we found that IL-17A and not IL-17F was 
upregulated 10 d after infection. In agreement with other publications, which pos-
tulated that IL-17A expression is markedly downregulated in T and B cells defi-
cient rag2-/- mice, [Ishigame et al., 2009], we found that during late infection IL-
17 was mainly produced by CD4 positive cells, most likely TH17 cells. However, 
2010 Sawa et al. revealed a small group of IL-17 secreting ILC3 named lymphoid 
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tissue inducer (LTi)-like cells that also express CD4. These LTi-like cells are pre-
sent in the intestine and apart from CD4 they are positive for RORγt, CCR6, 
CD25, CD127 and CD90 and they secrete IL-22, as well as IL-17 [Sonnenber 
and Artis, 2015]. Moreover, activation of LTi-like ILC3 was described to be micro-
biota-driven [Satoh-Takayama et al., 2008]. Beside CD4 and RORγt, TH17 cells 
are also positive for IL-6R, IL-23R, CCR4, CCR6, TGF-βRII and most importantly 
TCR [Wacleche et al., 2016]. For this reason, staining for TCR might be helpful 
to exclude ILC3s as IL-17A co-producers during infection with C. rodentium. qRT-
PCR, ELISA and flow cytometric analysis revealed that IL-17A expression was 
significantly lower in absence of commensal bacteria, although flow cytometric 
analysis revealed that only absolute IL-17+-cell numbers and not frequencies 
were decreased in monocolonised mice. Stimulation with Ionomycin and PMA 
prior to antibody staining, might be an explanation for that. Ionomycin and PMA 
mimic T cell-activation through TCR signalling and CD28 co-stimulation, leading 
to NF-κB activation [Macian et al., 2002]. This unphysiological, TCR and CD28 
independent activation of T cells may artificially activate T cells derived from GF 
mice, thus not reflecting the in-vivo situation. However, in our experimental set 
up, significantly lower levels of colonic IL-17A were detected in absence of com-
mensal, which is not in accordance with the recent published finding of Kamada 
et al., who 2012 claimed similar IL-17A expressions in the colon of GF and SPF 
mice on d 12 p.i.  This discrepancy can be explained by the time of analysis. 
While Kamada et al. analysed the expression of IL-17 on d 12 p.i., we compared 
the peak of IL-17A expression on d 8 and d 10 p.i. in GF and SPF mice, respec-
tively. This accuracy enabled us to measure significantly less colonic IL-17A in 
absence of gut microbiota.   
With these data, we could extend published data, by showing that IL-17A, but not 
IL-17F is important for defence against C. rodentium and that this proinflamma-
tory cytokine is expressed either by TH17 cells or by group 3 ILCs. Contrary to 
published data, we could show that colonic IL-17A expression is significantly 
downregulated in absence of intestinal microbiota.  
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5.8. Colonic CXCL2 secretion is decreased in absence of IL-17A 
and gut microbiota 
 
CXCL1, CXCL2, CXCL5 and CXCL9 were all shown to be upregulated in the 
colon of conventional mice 7 days after infection with C. rodentium, but only 
CXCL2 was shown to be highly upregulated 7-10 d p.i. [Spehlmann et al., 2009]. 
This nicely agrees with our data because we observed a massive upregulation of 
CXCL2 but not CXCL1 expression on day 10. p.i.. Since microbiota influences 
CXCL2 expression, it makes sense that CXCL2 expression is massively down-
regulated in absence of gut microbiota during infection. The finding that CXCL2 
expression is downregulated in il-17a/f-/- mice is interesting and shows the influ-
ence of IL-17 on CXCL2 expression during infections with the enteropathogen. 
As IL-17 has also be shown to influence CXCL5 and G-CSF [Onishi and Gaffen, 
2010] expression, it would be interesting to investigate the expression of these 
neutrophilic chemokines in normofloric and GF mice during C. rodentium infec-
tion. Finally, it would be interesting to infect cxcl2-/- mice with C. rodentium and 
to quantify neutrophil counts in the colon, in order to investigate the impact of 
CXCL2 on neutrophil recruitment to sites of C. rodentium infection. 
Summarising, in agreement with other publications, our data indicate upregula-
tion of CXCL2 during C. rodentium-infection. Furthermore, our findings extend 
the present knowledge, by showing that this CXCL2 upregulation occurs in an IL-
17- and gut microbiota-dependent manner during infection with C. rodentium.  
 
5.9. Attraction of neutrophils by the gut microbiota induces clear-
ance of C.rodentium  
 
Association of C. rodentium monocolonised mice with normal gut microbiota re-
duced pathogen titre by competing for nutrients [Kamada et al. 2012] We here 
show, that nutrient competition might partially but not fully explain the effects of 
microbiota. Instead, we here claim that the elemental function of the microbiota 
is to activate and direct neutrophils to the site of infection. This was supported by 
a detailed analysis of C. rodentium load after transplantation of microbiota in GF 
mice. After faecal transplantation, we observed a biphasic drop of the pathogen 
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load. The first occurred between d 4 and 6 p.i. which might be explained by bac-
terial competition because commensals were transferred 3 d p.i. and probably 
need 1-2 d to distribute and extrude C. rodentium. The second drop occurred on 
d 10 p.i. and correlates with migration of neutrophils to the site of infection, sug-
gesting that bacterial reduction at this time point is immune-mediated. The exper-
iment of faecal transplantation clearly shows restoration of neutrophil migration 
comparable to SPF mice. This might open a new treatment approach for patients 
that carry enteropathogenic bacteria.  
Our data extend current observations that transplantation of faecal microbiota not 
only decreases pathogen load, but also restores neutrophil migration and there-
fore initiates clearance.  
 
5.10. Gut microbiota enhances colonic IL-17A and CXCL2 expres-
sion 
 
Before, we showed that absence of gut microbiota results in decreased levels of 
IL-17A and CXCL2 in the colon during C. rodentium infection. With this experi-
ment, we were able to show that faecal microbiota transplantation enhanced co-
lonic IL-17A and CXCL2 in former monocolonised mice, resulting in enhanced 
neutrophil influx and clearance of the pathogen. Although it is known that com-
mensal bacteria stimulate expression of IL-17A and CXCL2, the influence of C. 
rodentium infection on expression of these soluble factors has not yet been in-
vestigated in the presence, absence or reconstitution of gut microbiota. We could 
show that the immunostimulating effect of C. rodentium alone is insufficient to 
induce adequate IL-17 and CXCL2 expression, thus additional stimulation of 
commensal bacteria was required to enhance this expression, and consequently 
stimulate neutrophil migration which is required for pathogen clearance. Thus, it 
would be interesting to identify specific bacterial species which are able to stim-
ulate neutrophil migration. SFB are known to induce IL-17 expression, therefore 
a transfer of these bacteria to monocolonised mice would be interesting in order 
to evaluate the impact of SFB on IL-17 and CXCL2 induction, as well as on neu-
trophil influx and bacterial clearance. Also, bacterial products like butyrate were 
shown to induce CXCL2 expression [Ohno et al., 1997]. Therefore, butyrate in 
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the drinking water of C. rodentium-monocolonised mice might also impact on 
CXCL2 expression and neutrophil influx. Moreover, it would be worth investigat-
ing the impact of the E. coli strain, used by Kamada, on IL-17A and CXCL2 ex-
pression [Kamada et al. 2015]. 
Although further work needs to be done to identify single neutrophil recruiting 
bacterial species, we could show that administration of total gut microbiota trig-
gers IL-17A and CXCL2 expression in response to C. rodentium. 
 
5.11. Gut microbiota does not impair neutrophil CXCR2 expression 
  
As it has been shown that commensal bacteria enhance the activity of neutrophils 
[Morland and Midvedt, 1984] and since we found that in C. rodentium infection, 
expression of CXCL2 is dependent on gut microbiota, we wondered whether the 
presence of the microbiota also affects the expression of the CXCL2 receptor 
(CXCR2) on neutrophils. For this reason, we measured by qRT-PCR the expres-
sion of cxcr2 in presence and absence of gut microbiota. Interestingly, neutrophils 
from SPF mice did not express increased cxcr2 as compared to neutrophils from 
GF mice. In contrast, although not significant, GF-derived neutrophils showed 
even slightly higher cxcr2 mRNA expression. These are new findings, showing 
that gut microbiota does not enhance CXCR2 expression in neutrophils and thus 
can be excluded to directly influence persistance of C. rodentium in GF mice. 
Although mature neutrophils can be found in bone marrow [Petrides and 
Dittmann, 1990], it is possible that commensal bacteria additionally influence neu-
trophils directly in the intestine. For this reason, it might be useful, to isolate neu-
trophils directly from the intestine for analysis of cxcr2 mRNA expression.  
In summary, we here demonstrated that the gut microbiota does not influence the 
expression of CXCR2 in bone marrow-derived neutrophils. 
 
5.12. Gut microbiota influences ICAM-1 expression 
 
ICAM-1 is one of the important adhesion molecules involved in neutrophil migra-
tion [Bunting et al., 2002]. It is known to be upregulated by bacterial components, 
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such as LPS [Huang et al., 1996] and during inflammation [Dustin et al., 1986]. 
Further, ICAM-1 expression was not only detected on endothelial cells but also 
on enterocytes [Kaiserlian et al., 1991]. However, the expression of ICAM-1 dur-
ing infection with C. rodentium and the impact on clearance have not yet been 
investigated. Our data clearly showed that infections with LPS-containing C. ro-
dentium alone were not sufficient to fully induce colonic ICAM-1 expression. Ra-
ther, the presence of commensal bacteria was required for adequate ICAM-1 ex-
pression, enabling neutrophil influx and clearance. Also, association of C. ro-
dentium-monocolonised mice with gut microbiota enhanced ICAM-1 expression 
significantly. Further, immunohistological staining revealed that ICAM-1 expres-
sion seems to be expressed on endothelial cells of small capillaries of the colonic 
crypts. In accordance with previous reports [Albanesi et al., 1999], we found that 
IL-17 strongly influences ICAM-1 expression in the colon during infection with C. 
rodentium, since expression was strongly downregulated in il-17a/f-/- mice. More-
over, INF-γ [Chang et al., 2002] and TNF-α [Griffin et al., 2012] were shown to 
upregulate ICAM-1 expression. Together with IL-17A, these cytokines were sig-
nificantly downregulated in absence of intestinal microbiota, suggesting microbi-
ota as essential mediator to regulate ICAM-1 expression in C. rodentium-mono-
colonised mice and thus enhancing the neutrophil influx. It would be interesting 
to induce LPS, in addition to C. rodentium, to see if this can further enhance 
ICAM-1 expression. Moreover, icam-1-/- mice should be infected with C. ro-
dentium and the impact on neutrophil migration and bacterial clearance should 
be investigated. 
Although further experiments need to be done, these data suggest gut microbiota 
induced ICAM-1 to be involved in neutrophil migration and therefore clearance.  
5.13. Involvement of the complement system in neutrophil migration 
 
The complement system is an important defence mechanism against pathogens. 
Anaphylatoxins C3a and C5a recruit neutrophils and cleavage products of C3b 
opsonise bacteria for a more sufficient uptake [Budzko et al., 1971]. 2011, Balzer 
et al., put the complement system into the focus of C. rodentium infection, by 
showing its presence in the intestine and by publishing that c3-/- mice suffer from 
enhanced mortality, compared to WT mice. We also observed the involvement of 
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the complement system in defence against C. rodentium, not with respect to en-
hanced mortality but to delayed pathogen clearance in absence of C3. Interesting 
is the finding that c3-/-, but not c5-/- mice displayed delayed clearance. Although 
cleavage products of C3 are required for cleavage of C5 [Shin et al., 1968], a C3-
independent mechanism for C5 cleavage was described 2012 by Auger et al., 
which involves the coagulation cascade. Therefore, in the absence of C3, C3a 
and C3b opsonins the C5 cascade continues and still results in cleavage of C5 
into C5a and C5b and finally in MAC formation. The facts that c5-/- mice cleared 
as fast as WT mice while C3 deficiency showed delayed clearance, suggest that 
MAC is not important for eradication of C. rodentium. Moreover, anaphylatoxin 
C3a seems to be more important than C5a, although C5a was published to be 
more potent in neutrophil recruitment than C3a [Markiewski and Lambris, 2007]. 
In agreement with other publications [Balzer et al., 2011], we could show that the 
absence of C3 led to impaired neutrophil influx in the colon in response to C. 
rodentium. However, the neutrophil numbers in blood were not affected, showing 
that only migration from blood into colon is affected in c3-/- mice. In order to in-
vestigate the influence of commensal bacteria on complement activation during 
infection, it would be interesting to measure and compare colonic C3a and C3b 
cleavage products in presence and absence of gut microbiota.  
Our data clearly show the involvement of the complement system in defence 
against C. rodentium and suggest C3a and C3b opsonins, but not C5a and MAC 
as key-players, thereby extending published data. 
 
5.14. Gut microbiota enhances colonic IgG expression  
 
Although IgG was shown to be crucial for defence against C. rodentium [Maaser 
et al., 2004], Kamada et al. published 2012 that GF and SPF mice harbour similar 
levels of Citrobacter-specific IgG in the serum on d 12 p.i. with C. rodentium. 
Further, they demonstrated that this IgG selectively binds virulent bacteria in the 
intestinal lumen, leading to selective elimination by neutrophils [Kamada et al., 
2015]. Our investigations clearly demonstrated the importance of the right timing 
of several immune components for efficient immunity against C. rodentium. We 
77 
 
therefore performed kinetic analysis of C. rodentium-specific IgG in serum, su-
pernatants of cultured colonic tissues and colonic lumen in presence and ab-
sence of intestinal microbiota. We found upregulation of IgG levels during course 
of infection. Further, we could confirm Kamadas data regarding IgG concentra-
tions in serum. Importantly, comparison of colonic IgG levels at the peak of neu-
trophil influx revealed drastically downregulated antibody levels in GF animals as 
compared to C. rodentium infected SPF animals. These IgG levels were en-
hanced by faecal microbiota transplantation, showing the direct impact of com-
mensal bacteria on colonic C. rodentium-specific IgG expression. Reasons for 
this low IgG levels might be i) defects, either in the migration of IgG-secreting 
plasma cells into the colon ii) the activity of these cells or iii) the translocation of 
IgG itself. It is already known that upon activation by T cells or DCs, plasma cells 
secrete different immunoglobulins in the mucosal lamina propria [Rojas and Apo-
daca, 2002]. Contrary to IgA- or IgM-intestinal translocation, there is little 
knowledge about the translocation of IgG into the intestine. In neonatal rats, it 
was shown that after secretion, IgG binds to neonatal FcR (FcRn), present on 
intestinal enterocytes and is then transported to the intestinal lumen by endocy-
tosis [Pyzik et al., 2015]. Probably, the general production and secretion of IgG 
by plasma cells is not affected by gut microbiota because of the normal IgG levels 
in serum in C. rodentium-monocolonised mice. Specific defects in intestinal B 
cells and/or B cell activation by T cells or DCs are conceivable. However, it is 
more likely that IgG translocation is microbiota dependent. To investigate this, it 
would be helpful to analyse i) plasma cell, T cell and DC counts in colonic lamina 
propria, ii) the process of B cell activation and iii) to quantify FcR expression on 
enterocytes, binding of IgG to its receptors and endothelial IgG-endocytosis effi-
ciency in presence and absence of gut microbiota.  
Although little is known we could clearly show that commensal bacteria affect 
colonic IgG levels and therefore enhances pathogen uptake by phagocytes.  
 
5.15. Gut microbiota increases phagocytic activity of neutrophils 
 
Phagocytic activity is stimulated by gut microbiota [Morland and Midvedt, 1984] 
and it has been shown that mature neutrophils migrate from the bone marrow into 
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blood vessels and from there to sites of infection [Petrides and Dittmann, 1990]. 
Unknown is if C. rodentium alone enhances neutrophil phagocytosis to a similar 
level, reached in presence of gut microbiota. With this experiment, we could show 
that C. rodentium, together with a complex gut microbiota enhances the phago-
cytic activity of neutrophils more than C. rodentium alone. The inefficient uptake 
of pathogens in absence of commensals might be another reason for persistence 
of C. rodentium in GF mice. The phagocytic uptake is probably IgG- and FcγR-
mediated, since they were shown to be involved in defence against C. rodentium 
[Maaser et al., 2004; Masuda et al., 2008]. For this reason, the low levels of co-
lonic IgG in GF mice probably further decrease phagocytic efficiency. In order to 
investigate this, it would be useful i) to opsonise C. rodentium with IgG to show 
the effect of IgG-opsonisation on phagocytic activity of GF and SPF derived neu-
trophils and ii) to opsonise C. rodentium with GF and SPF derived IgG to show 
the effect of different IgG levels on phagocytic activity. To ensure that the phag-
ocytic defects, shown for bone marrow neutrophils, are also true for intestinal 
neutrophils, assays with colon derived neutrophils should be performed.  
With this experiment, we were able to extend the current knowledge by showing 
that gut microbiota enhances not only the phagocytic activity under steady state 
condition, but also after infection with C. rodentium. 
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7. Abbreviations 
 
AKP   Alkaline phosphatase 
A/E   Attaching-and-effacing 
BCR   B cell receptor 
BSA   Bovine serum albumin  
BSS   Balanced salts solution 
cDNA   Complementary DNA 
CFU   Colon forming unit 
cm   Centimetre 
CR   Complement receptor 
CXCR   Chemokine receptor 
C. rodentium  Citrobacter rodentium 
d   Day 
DC   Dendritic cell 
DNA   Deoxyribonucleic acid 
dNTP   Ducleotide triphosphates 
E. coli   Escherichia coli 
EDTA   Ethylenediaminetetraacetic acid 
EHEC   Enterohemorrhagic E. coli 
ELISA   Enzyme-linked immunosorbent assay 
EPEC   Enteropathogenic E. coli 
et al.   et alii 
FCS   Fetal calf serum 
g   Gramm 
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G-CSF  Granulocyte colony stimulating factor 
GF   Germ free 
GFM   GF associated with microbiota 
GLYCAM1  Glycosylation-dependent cell adhesion molecule-1 
GM-CSF  Granulocyte-macrophage-CSF 
H   Hour(s) 
HBSS   Hank´s Balanced Salt Solution 
HE   Hematoxylin and eosin 
HEPES  4-(2-hydroxyethyl)-1-piperazineethano- Sulfonic acid 
H2O2   Hydrogenperoxide 
ICAM   Intercellular adhesion molecule 
IFN-γ   Interferon gamma 
IL   Interleukin 
ILC   Innate lymphoid cell 
i.e.   id est  
i.p.   Intraperitoneal 
i.v.   Intravenous 
FcγR   Fc-receptors which bind immunoglobulin G 
LB   Lysogen broth 
LEE   Locus of enterocyte effacement 
LPS   Lipopolysaccharide 
MAC   Membrane attack complex 
MACS  Magnetic cell separation 
MBL   Mannose-binding lectin 
MHC   Major histocompatibility complex 
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min   Minute(s) 
mL   Millilitre(s) 
mm   Millimetre(s) 
MPO   Myeloperoxidase 
mRNA  Messenger RNA 
MyD88  Myeloid differentiation primary response gene 88 
NaCl   Sodium chloride 
NADPH  Nicotinamide adenine dinucleotide phosphate 
NaHCO3  Sodium hydrogen carbonate 
NET   Neutrophil extracellular trap 
NF-κB   Nuclear factor kappa-light-chain-enhancer of activated B 
cells 
NH4Cl  Ammonium chloride 
NK   Natural killer 
ON   Over night 
O2-   Superoxide anion 
PAMP   Pattern-associated molecular patterns 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
PMA   Phorbol 12-myristate 13-acetate 
PMN   Polymorphonuclear neutrophilic leukocytes 
PRR   Pattern recognition receptor 
PSGL-1  P-selectin/ligand 1 
p.i.   Post infection 
qRT-PCR  Quantitative real-time PCR 
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RNA   Ribonucleic acid 
ROS   Reactive oxygen species 
RPMI   Roswell Park Memorial Institute medium 
Rpm   Revolutions per minute 
SCFA   Short chain fatty acid 
SFB   Segmented filamentous bacteria 
SPF   Specific pathogen free 
TEM   Transepithelial migration 
TH   T helper cell 
TIR   Toll/IL-1R homology 
TIRAP  TIR domain-containing adaptor 
TLR   Toll-like receptor 
TNF-α  Tumor necrosis factor alpha 
Treg   Regulatory T cell 
T3SS   Type III secretion system 
VCAM  Vascular cell adhesion protein 
µL   Microlitre(s) 
µm   Micrometre(s) 
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